setID	setSize	setScore	N	setP	setQ	setName	setID.orig
101	139	72.0727534475851	139	1e-04	0.105075293347846	Adrenergic signaling in cardiomyocytes	66
777	64	45.1243789952505	64	5e-04	0.140896416080066	Collagen biosynthesis and modifying enzymes	306
526	37	27.8687976446837	37	9e-04	0.140896416080066	Regulation of RAC1 activity	1356
1102	21	31.8811023491136	21	0.0012	0.140896416080066	Initial triggering of complement	797
685	519	133.546099029775	519	0.0013	0.140896416080066	Axon guidance (REACTOME)	162
778	44	34.6365993940081	44	0.0016	0.140896416080066	Collagen chain trimerization	307
924	282	94.667941292473	282	0.0016	0.140896416080066	Extracellular matrix organization	516
412	138	56.4074412608416	138	0.002	0.140896416080066	Wnt signaling pathway	1860
796	65	52.7017094822296	65	0.0021	0.140896416080066	Costimulation by the CD28 family	333
220	15	18.2843251644207	15	0.0022	0.140896416080066	Glycosphingolipid biosynthesis - ganglio series	669
174	80	43.7067704252641	80	0.0024	0.140896416080066	ECM-receptor interaction	458
1362	103	59.1291064886136	103	0.0025	0.140896416080066	Phase 1 - Functionalization of compounds	1173
780	87	47.4936709249081	87	0.0026	0.140896416080066	Collagen formation	309
338	155	60.472850544088	155	0.0027	0.140896416080066	Protein processing in endoplasmic reticulum	1272
677	57	36.4789377152578	57	0.0027	0.140896416080066	Assembly of collagen fibrils and other multimeric structures	137
877	26	22.2215783982381	26	0.0027	0.140896416080066	Downregulation of TGF-beta receptor signaling	435
1702	16	16.1053914548656	16	0.0029	0.140896416080066	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1691
1372	20	34.2515256903505	20	0.0031	0.140896416080066	Phosphorylation of CD3 and TCR zeta chains	1187
1778	17	34.5705287942351	17	0.0031	0.140896416080066	Translocation of ZAP-70 to Immunological synapse	1773
336	84	43.4651417401168	84	0.0032	0.140896416080066	Protein digestion and absorption	1268
1359	178	75.6954977688028	178	0.0034	0.140896416080066	Peptide ligand-binding receptors	1166
358	85	54.859361914579	85	0.0035	0.140896416080066	Rheumatoid arthritis	1401
169	86	43.8751763733778	86	0.0036	0.140896416080066	Dilated cardiomyopathy	404
1434	34	25.0047703295573	34	0.0037	0.140896416080066	RHO GTPases Activate WASPs and WAVEs	1412
1183	99	54.7993465410173	99	0.0039	0.140896416080066	MHC class II antigen presentation	957
1324	21	33.4175002606825	21	0.0039	0.140896416080066	PD-1 signaling	1156
694	16	16.9232940496249	16	0.004	0.140896416080066	Beta-catenin phosphorylation cascade	178
387	102	59.8976975252728	102	0.0041	0.140896416080066	Th17 cell differentiation	1694
635	17	17.1705058152036	17	0.0042	0.140896416080066	Activation of SMO	41
178	244	75.0460227606388	244	0.0044	0.140896416080066	Endocytosis	470
1015	28	32.4959547342894	28	0.0045	0.140896416080066	Generation of second messenger molecules	627
107	34	47.3226469172835	34	0.0047	0.140896416080066	Allograft rejection	78
124	27	38.826117678939	27	0.0047	0.140896416080066	Asthma	142
399	41	50.5820268161788	41	0.0048	0.140896416080066	Type I diabetes mellitus	1807
1701	32	23.6756704597421	32	0.005	0.140896416080066	TGF-beta receptor signaling activates SMADs	1690
195	190	63.0676055350718	190	0.0051	0.140896416080066	Focal adhesion	559
373	53	48.7664972621254	53	0.0052	0.140896416080066	Staphylococcus aureus infection	1605
226	37	43.9354418386508	37	0.0053	0.140896416080066	Graft-versus-host disease	684
410	54	43.5149726309521	54	0.0053	0.140896416080066	Viral myocarditis	1846
146	130	59.8775752987594	130	0.0055	0.140896416080066	Cell adhesion molecules (CAMs)	241
275	271	84.1003716741543	271	0.0055	0.140896416080066	MicroRNAs in cancer	959
1029	119	49.9164542660519	119	0.0057	0.140896416080066	Glycerophospholipid biosynthesis	652
122	68	36.1847695609038	68	0.0058	0.140896416080066	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	134
735	135	54.2479412687467	135	0.0059	0.140896416080066	Cardiac conduction	220
1489	26	29.4024873235098	26	0.0066	0.153989654044256	Regulation of Complement cascade	1331
653	13	13.479206177158	13	0.007	0.153989654044256	Advanced glycosylation endproduct receptor signaling	67
242	61	41.320381882913	61	0.0072	0.153989654044256	Inflammatory bowel disease (IBD)	786
115	68	57.7060298199491	68	0.0073	0.153989654044256	Antigen processing and presentation	103
1506	19	16.4828488039024	19	0.0074	0.153989654044256	Regulation of TP53 Activity through Methylation	1368
1236	194	64.2504264883199	194	0.0075	0.153989654044256	Muscle contraction	1005
394	107	51.9880799194301	107	0.0077	0.153989654044256	Toxoplasmosis	1732
757	46	41.822121379272	46	0.0077	0.153989654044256	Chemokine receptors bind chemokines	266
231	90	50.256980543825	90	0.0078	0.153989654044256	Hematopoietic cell lineage	707
878	92	45.179923242157	92	0.008	0.153989654044256	Downstream TCR signaling	443
591	13	13.1294736742447	13	0.0081	0.153989654044256	AMER1 mutants destabilize the destruction complex*	85
181	191	64.4591329683459	191	0.0083	0.153989654044256	Epstein-Barr virus infection	493
388	14	13.8941027873415	14	0.0084	0.153989654044256	Thiamine metabolism	1702
1217	14	13.3032006552284	14	0.0085	0.153989654044256	Misspliced GSK3beta mutants stabilize beta-catenin*	967
1678	27	18.9341266174	27	0.0096	0.170532033466176	Synthesis of PC	1656
782	43	30.7493513246345	43	0.0098	0.170532033466176	Complement cascade	314
769	295	82.935934930923	295	0.0099	0.170532033466176	Class A/1 (Rhodopsin-like receptors)	293
250	43	31.0534171536756	43	0.0109	0.184729144756696	Intestinal immune network for IgA production	834
229	247	72.5934700624817	247	0.0118	0.193399452973571	HTLV-I infection	749
386	88	42.403978977449	88	0.0118	0.193399452973571	Th1 and Th2 cell differentiation	1693
240	80	35.6143803632725	80	0.012	0.193399452973571	Hypertrophic cardiomyopathy (HCM)	760
139	141	48.3817143020531	141	0.0122	0.193399452973571	Breast cancer	196
726	22	16.4372935431872	22	0.0126	0.193399452973571	CTLA4 inhibitory signaling	341
1120	90	47.6605335695277	90	0.0127	0.193399452973571	Interferon gamma signaling	822
1247	36	21.9014962693412	36	0.0127	0.193399452973571	NCAM1 interactions	1023
1441	20	14.9282816988724	20	0.0145	0.217655964791966	RIP-mediated NFkB activation via ZBP1	1419
61	10	11.9735484359439	10	0.0153	0.219828574240888	triacylglycerol degradation	1790
135	70	30.9927067013331	70	0.0155	0.219828574240888	Bile secretion	185
166	258	87.8458983085311	258	0.0155	0.219828574240888	Cytokine-cytokine receptor interaction	352
235	150	48.2623012685899	150	0.0156	0.219828574240888	Hippo signaling pathway	728
815	13	11.620573152175	13	0.0158	0.219828574240888	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	402
125	49	40.6453467341546	49	0.0159	0.219828574240888	Autoimmune thyroid disease	156
421	24	16.2583407399315	24	0.0163	0.222121189735319	ALK1 signaling events	76
234	171	62.7376952247582	171	0.0166	0.222121189735319	Herpes simplex infection	719
890	55	26.3414685227115	55	0.0167	0.222121189735319	ECM proteoglycans	457
1395	29	19.049125610333	29	0.0176	0.228061148061801	Pre-NOTCH Transcription and Translation	1243
260	61	27.0849860316966	61	0.0177	0.228061148061801	Longevity regulating pathway - multiple species	891
852	13	11.4576871658556	13	0.0183	0.228061148061801	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	393
1137	53	26.2381316574439	53	0.0183	0.228061148061801	Ion homeostasis	842
1708	27	20.2106514169002	27	0.0186	0.228061148061801	TNFs bind their physiological receptors	1720
43	10	9.55832261562414	10	0.0189	0.228061148061801	reactive oxygen species degradation	1310
1483	13	11.5234536385546	13	0.0189	0.228061148061801	Reduction of cytosolic Ca++ levels	1317
379	124	77.7483523627513	124	0.0191	0.228061148061801	Systemic lupus erythematosus	1667
1337	86	34.3544606179449	86	0.0191	0.228061148061801	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	1203
1272	93	35.6446743108089	93	0.0195	0.229566673509967	Negative regulation of the PI3K/AKT network	1036
423	54	25.1295690179009	54	0.02	0.229566673509967	ATF-2 transcription factor network	144
719	28	16.7304529662	28	0.0201	0.229566673509967	COPI-independent Golgi-to-ER retrograde traffic	329
1293	12	10.8496595175871	12	0.0201	0.229566673509967	Notch-HLH transcription pathway	1079
1662	79	31.3062196167594	79	0.022	0.247038721594403	Sphingolipid metabolism (REACTOME)	1596
477	26	16.3727379565776	26	0.0221	0.247038721594403	Glypican 1 network	676
817	36	18.8178622473768	36	0.0225	0.248359784276726	DNA Damage Recognition in GG-NER	419
97	11	12.0685527711658	11	0.0228	0.248359784276726	Acylglycerol degradation	53
1057	23	16.0454932379456	23	0.0232	0.248359784276726	HSF1-dependent transactivation	748
381	84	33.0104070921809	84	0.0234	0.248359784276726	TGF-beta signaling pathway	1692
1420	24	14.8907678897507	24	0.0234	0.248359784276726	Pyrimidine metabolism (REACTOME)	1292
561	55	24.7392832520823	55	0.024	0.250564161060247	TCR signaling in naive CD4+ T cells	1680
1663	16	12.1363447546235	16	0.0243	0.250564161060247	Spry regulation of FGF signaling	1601
805	722	134.180728520365	722	0.0246	0.250564161060247	Cytokine Signaling in Immune system	351
307	330	76.5010041653081	330	0.0247	0.250564161060247	PI3K-Akt signaling pathway	1200
219	18	14.1432915408015	18	0.0248	0.250564161060247	Glycosaminoglycan degradation	667
1264	32	18.3191884469692	32	0.0253	0.251395094364939	Negative regulation of FGFR1 signaling	1029
1699	110	39.9974984666436	110	0.0255	0.251395094364939	TCR signaling	1679
1830	24	14.5374040643295	24	0.0256	0.251395094364939	ZBP1(DAI) mediated induction of type I IFNs	1866
1696	25	14.6293980796371	25	0.0266	0.256422275509421	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1670
1750	118	37.7103963615095	118	0.0266	0.256422275509421	Toll Like Receptor 4 (TLR4) Cascade	1724
804	65	33.3965433753854	65	0.0269	0.256956853732459	Cytochrome P450 - arranged by substrate type	350
1548	129	41.3279344233596	135	0.0273	0.258428424179836	Role of LAT2/NTAL/LAB on calcium mobilization*	1454
209	50	23.3854945277675	50	0.0279	0.259923094070986	Glycerolipid metabolism	651
906	26	14.674325031064	26	0.028	0.259923094070986	Effects of PIP2 hydrolysis	459
391	72	27.8234395005219	72	0.0282	0.259923094070986	Thyroid hormone synthesis	1708
1382	16	11.3899970002555	16	0.0285	0.260403987862052	Platelet sensitization by LDL	1220
1377	37	18.8590453200641	37	0.029	0.262688233369614	Platelet Aggregation (Plug Formation)	1216
79	61	26.3378114106888	55	0.0304	0.271076597124274	Human T-lymphotropic virus (ssRNART)	756
323	138	41.05183283374	138	0.0307	0.271076597124274	Phospholipase D signaling pathway	1184
396	12	10.047350672827	12	0.0307	0.271076597124274	Triacylglycerol biosynthesis	1789
314	381	77.4135605686281	381	0.0313	0.271806337337816	Pathways in cancer	1149
1636	11	9.48969243207841	11	0.0313	0.271806337337816	Signaling by NOTCH4	1549
85	14	10.7259691150707	14	0.032	0.273195762704399	Murine Leukemia Virus (ssRNART)	1004
862	30	16.7126920284272	30	0.0322	0.273195762704399	Disassembly of the destruction complex and recruitment of AXIN to the membrane	407
325	120	38.2637688984198	120	0.0326	0.273195762704399	Platelet activation	1213
1237	78	27.805693644963	78	0.0335	0.273195762704399	MyD88 cascade initiated on plasma membrane*	1006
60	16	11.4014477727992	16	0.0337	0.273195762704399	triacylglycerol biosynthesis	1788
44	17	12.5695665101789	17	0.0338	0.273195762704399	retinol biosynthesis	1394
1059	82	29.5480205733525	82	0.0338	0.273195762704399	Hedgehog 'on' state	703
433	28	14.9397819420421	28	0.034	0.273195762704399	BARD1 signaling events	166
130	74	26.893513931204	74	0.0342	0.273195762704399	Bacterial invasion of epithelial cells	165
513	21	12.6664894601413	21	0.0344	0.273195762704399	PDGFR-alpha signaling pathway	1157
1654	221	53.8481960327242	221	0.0347	0.273195762704399	Signaling by the B Cell Receptor (BCR)	1558
1828	24	20.1491900665808	24	0.0348	0.273195762704399	Xenobiotics	1864
615	107	33.5316554574275	107	0.0349	0.273195762704399	Activated TLR4 signalling	20
1640	39	18.4962104789495	39	0.0351	0.273195762704399	Signaling by Retinoic Acid	1553
891	24	13.7164954817065	24	0.0355	0.27427742013592	EGFR downregulation	461
1240	93	30.8383160858401	93	0.0362	0.277644205780439	MyD88-independent TLR3/TLR4 cascade*	1009
407	43	19.0840084848183	43	0.0366	0.278677951922547	Vasopressin-regulated water reabsorption	1833
1276	40	18.3444806353161	40	0.0374	0.279017501930428	Netrin-1 signaling	1042
186	38	21.0174816173863	38	0.0376	0.279017501930428	Fat digestion and absorption	522
904	13	9.95473968892519	13	0.0377	0.279017501930428	ERKs are inactivated	506
1241	87	28.8850350801042	87	0.0379	0.279017501930428	MyD88:Mal cascade initiated on plasma membrane*	1010
302	18	11.366622048195	18	0.0383	0.279017501930428	Other glycan degradation	1118
896	41	18.589698738217	41	0.0385	0.279017501930428	EPHB-mediated forward signaling	486
609	25	14.58222444044	25	0.0389	0.279017501930428	Abortive elongation of HIV-1 transcript in the absence of Tat	12
1132	40	18.4957706158868	40	0.0391	0.279017501930428	Intraflagellar transport	837
1379	30	16.4844842919179	30	0.0391	0.279017501930428	Platelet calcium homeostasis	1217
1698	227	64.8959277211131	227	0.0393	0.279017501930428	TCF dependent signaling in response to WNT	1678
372	125	37.0251270926487	125	0.0397	0.279965714490568	Spliceosome	1600
145	69	26.5866991543507	69	0.0403	0.279974813888131	Cardiac muscle contraction	221
1154	25	14.6493610166503	25	0.0409	0.279974813888131	Laminin interactions	869
1378	263	59.4712916819892	263	0.0409	0.279974813888131	Platelet activation, signaling and aggregation	1214
1012	420	79.74502520186	420	0.041	0.279974813888131	Gastrin-CREB signalling pathway via PKC and MAPK	624
880	191	47.4159246590777	191	0.0411	0.279974813888131	Downstream signaling events of B Cell Receptor (BCR)	437
1266	28	14.9080802869761	28	0.0413	0.279974813888131	Negative regulation of FGFR3 signaling	1031
1072	20	13.1821662753712	20	0.0419	0.280627917599734	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	742
1062	596	107.51858817691	596	0.0423	0.280627917599734	Hemostasis	709
339	197	47.9577144679128	197	0.0427	0.280627917599734	Proteoglycans in cancer	1276
295	48	20.0968018012795	48	0.0433	0.280627917599734	Notch signaling pathway (KEGG)	1077
106	36	17.0417270994835	36	0.0435	0.280627917599734	Aldosterone-regulated sodium reabsorption	75
682	15	11.3828916786311	15	0.0435	0.280627917599734	Attenuation phase	148
1831	10	8.02824038866882	10	0.0435	0.280627917599734	Zinc influx into cells by the SLC39 gene family	1867
1648	324	76.3193791036669	324	0.0436	0.280627917599734	Signaling by Wnt	1561
1510	59	23.0402979706647	59	0.0438	0.280627917599734	Regulation of actin dynamics for phagocytic cup formation	1323
1318	18	11.0007586113731	18	0.0443	0.282111242139973	Other semaphorin interactions	1119
1267	30	15.5450084093283	30	0.0451	0.283273159259397	Negative regulation of FGFR4 signaling	1032
417	154	39.4552077079553	154	0.0455	0.283273159259397	cGMP-PKG signaling pathway	262
1355	30	15.3804619242017	30	0.0458	0.283273159259397	Pausing and recovery of Tat-mediated HIV elongation*	1151
1524	18	10.9464542173035	18	0.0458	0.283273159259397	Regulation of signaling by CBL	1360
525	25	13.6485369391997	25	0.0459	0.283273159259397	Regulation of CDC42 activity	1329
1076	12	9.79144715231413	12	0.0461	0.283273159259397	Hyaluronan uptake and degradation	759
1503	155	40.515581900568	155	0.047	0.287124348101671	Regulation of TP53 Activity	1365
913	11	9.43543516629502	11	0.0477	0.289716271253886	Endosomal/Vacuolar pathway	474
1798	98	32.4469491091789	98	0.048	0.289862878200953	UCH proteinases	1817
899	78	27.3093593547108	78	0.0487	0.29134513155539	ER-Phagosome pathway	496
953	355	69.3564531155867	355	0.0488	0.29134513155539	Fc epsilon receptor (FCERI) signaling	533
259	87	27.1163028502394	87	0.0494	0.29144568207534	Longevity regulating pathway	890
289	28	14.523003675857	28	0.0496	0.29144568207534	Nicotinate and nicotinamide metabolism	1057
131	55	21.6172173903692	55	0.0498	0.29144568207534	Basal cell carcinoma	167
155	69	23.400538801058	69	0.0502	0.29144568207534	Chronic myeloid leukemia	282
1357	13	10.274495728597	13	0.0506	0.29144568207534	Peptide hormone biosynthesis	1164
244	162	46.9091660999463	162	0.0508	0.29144568207534	Influenza A	788
1592	33	16.0174317030266	33	0.051	0.29144568207534	Sialic acid metabolism	1500
1246	262	56.382959577039	262	0.0511	0.29144568207534	NCAM signaling for neurite out-growth	1022
566	42	17.7419801290766	42	0.0514	0.29144568207534	Thromboxane A2 receptor signaling	1704
1672	23	12.2415701436495	23	0.0519	0.29144568207534	Synthesis and interconversion of nucleotide di- and triphosphates	1643
1394	18	10.6499453504176	18	0.0523	0.29144568207534	Pre-NOTCH Processing in Golgi	1242
1601	348	66.933448944907	348	0.0526	0.29144568207534	Signaling by EGFR	1512
1222	92	28.6506700585648	92	0.0527	0.29144568207534	Mitochondrial translation	971
1223	86	28.6506700585648	92	0.0527	0.29144568207534	Mitochondrial translation elongation*	972
1393	46	19.1000675664191	46	0.0533	0.293220583007339	Pre-NOTCH Expression and Processing	1241
527	42	17.1521201874425	42	0.0547	0.299355132610789	Regulation of RhoA activity	1359
809	24	12.2526939531523	24	0.0552	0.300526227606273	Cytosolic tRNA aminoacylation	357
1172	276	56.8719248305805	276	0.0558	0.301215840930491	MAPK family signaling cascades	910
112	65	22.3708356104099	65	0.0559	0.301215840930491	Amphetamine addiction	93
183	98	29.1517942468072	98	0.0564	0.301891451953709	Estrogen signaling pathway	508
176	46	18.5791831115586	46	0.0566	0.301891451953709	Endocrine and other factor-regulated calcium reabsorption	468
811	349	67.4723819884541	361	0.057	0.302489480849859	DAP12 interactions*	363
1033	11	9.13367848535463	11	0.0574	0.303081499405344	Glycoprotein hormones	662
1595	10	7.47129988160647	10	0.0581	0.304462069505465	Signal attenuation	1502
128	166	40.545940277574	166	0.0587	0.304462069505465	Axon guidance (KEGG)	161
1539	123	33.838130197987	123	0.059	0.304462069505465	Response to elevated platelet cytosolic Ca2+*	1389
1644	72	24.0022423137008	72	0.059	0.304462069505465	Signaling by TGF-beta Receptor Complex	1557
276	47	20.5946416919354	47	0.0594	0.304462069505465	Mineral absorption	960
1637	360	66.905452285938	360	0.0594	0.304462069505465	Signaling by PDGF	1550
943	23	12.4493441574041	23	0.0599	0.305073677787706	FRS-mediated FGFR1 signaling	581
1035	38	16.2611965028735	38	0.0601	0.305073677787706	Glycosphingolipid metabolism	672
400	45	17.4579762518501	45	0.0607	0.305218709248504	Type II diabetes mellitus	1809
1842	182	42.9628886810852	182	0.0609	0.305218709248504	mRNA Splicing*	993
1389	84	28.5925060139598	84	0.061	0.305218709248504	Post-translational modification: synthesis of GPI-anchored proteins	1233
1275	10	7.31924940668367	10	0.0614	0.305764123770508	Netrin mediated repulsion signals	1041
1200	92	26.4994828808897	92	0.0622	0.30828694557717	Metabolism of nucleotides	942
1722	24	12.3097499320667	24	0.0628	0.309361212507843	TRAF6 mediated NF-kB activation	1748
807	65	21.9525777100567	65	0.0632	0.309361212507843	Cytosolic sensors of pathogen-associated DNA	355
449	12	7.82618426915281	12	0.0633	0.309361212507843	Circadian rhythm pathway	288
893	93	27.4606057032018	93	0.064	0.311334202512135	EPH-Ephrin signaling	481
1112	66	23.4543152007797	66	0.0657	0.314748265073774	Integrin cell surface interactions	814
850	79	25.2581450929872	79	0.0658	0.314748265073774	Degradation of beta-catenin by the destruction complex	387
1404	20	11.0265935572437	20	0.0659	0.314748265073774	Processing of Intronless Pre-mRNAs	1256
1501	16	10.583685752754	16	0.0659	0.314748265073774	Regulation of TLR by endogenous ligand	1363
926	29	13.2942598650866	29	0.0668	0.317603149123805	FCERI mediated Ca+2 mobilization	537
230	44	16.8999546801513	44	0.0676	0.319937776606221	Hedgehog signaling pathway	706
1839	56	19.6654609393104	56	0.0679	0.319937776606221	mRNA 3'-end processing	988
1756	142	35.5149910104371	142	0.0687	0.322078616566222	Toll-Like Receptors Cascades	1731
310	93	28.7035150250103	93	0.0694	0.322078616566222	Pancreatic secretion	1143
351	199	43.5465300366935	199	0.0696	0.322078616566222	Regulation of actin cytoskeleton	1322
654	20	11.3335772930052	20	0.0697	0.322078616566222	Aflatoxin activation and detoxification	68
998	422	77.8347600086012	422	0.0701	0.322078616566222	GPCR ligand binding	682
1634	32	13.9280770158757	32	0.0704	0.322078616566222	Signaling by NOTCH2	1547
1692	19	9.95615512510342	19	0.0705	0.322078616566222	Synthesis, secretion, and deacylation of Ghrelin	1664
1258	15	8.81843706409658	15	0.0716	0.325687922238344	NRIF signals cell death from the nucleus	1085
602	11	7.80601607583906	11	0.0721	0.326548648723262	ATF6 (ATF6-alpha) activates chaperone genes	146
954	82	24.4408276166497	82	0.0738	0.330875391818748	Fcgamma receptor (FCGR) dependent phagocytosis	540
1304	13	8.8391711635996	13	0.0738	0.330875391818748	Nucleotide-like (purinergic) receptors	1098
528	63	20.3904406089599	63	0.074	0.330875391818748	Regulation of Telomerase	1362
1138	53	19.0379940474902	53	0.0745	0.331699548915869	Ion transport by P-type ATPases	843
247	102	27.2818708552521	102	0.0749	0.331932412040265	Insulin resistance	808
974	183	40.8942755004059	183	0.0753	0.331932412040265	G alpha (q) signalling events	589
170	126	31.0837272128644	126	0.0755	0.331932412040265	Dopaminergic synapse	430
745	69	21.7773304017082	69	0.0763	0.334051870101693	Cell death signalling via NRAGE, NRIF and NADE	246
552	38	14.8118507799911	38	0.0775	0.337804042250512	Signaling events regulated by Ret tyrosine kinase	1574
466	100	26.4040343963655	100	0.0778	0.337804042250512	ErbB1 downstream signaling	499
340	20	10.1761888231272	20	0.0795	0.343077162617665	Proximal tubule bicarbonate reclamation	1277
366	61	19.6466466629271	61	0.0801	0.343077162617665	Shigellosis	1499
1376	13	7.8885595957701	13	0.0802	0.343077162617665	Platelet Adhesion to exposed collagen	1215
32	10	7.02829144200042	10	0.0805	0.343077162617665	melatonin degradation I*	924
779	39	16.8699896850435	39	0.0808	0.343077162617665	Collagen degradation	308
473	37	14.3103190683416	37	0.0813	0.343077162617665	FOXM1 transcription factor network	578
1405	11	7.14981017745202	11	0.0813	0.343077162617665	Processive synthesis on the C-strand of the telomere	1257
1418	12	7.35435992577517	12	0.082	0.344646962180934	Purine salvage	1286
165	43	16.6342155894812	43	0.0826	0.345128730324347	Cysteine and methionine metabolism	349
784	11	7.13608234210471	11	0.083	0.345128730324347	Condensation of Prometaphase Chromosomes	316
1204	30	12.8958643115057	30	0.0831	0.345128730324347	Metabolism of steroid hormones	946
603	12	7.66235846759321	12	0.0835	0.345424684824611	ATF6 (ATF6-alpha) activates chaperones	147
1361	45	18.6325836733659	45	0.0851	0.350115745788381	Phase 0 - rapid depolarisation	1172
1177	10	6.56874129235659	10	0.0857	0.350115745788381	MASTL Facilitates Mitotic Progression	916
1661	41	15.0450231138858	41	0.0859	0.350115745788381	Sphingolipid de novo biosynthesis	1594
1328	21	10.6095988873242	21	0.0863	0.350115745788381	PI-3K cascade:FGFR1	1193
1558	21	10.5402936436569	21	0.0863	0.350115745788381	SHC-mediated cascade:FGFR1	1492
439	69	20.5845874699996	69	0.0877	0.351510873429843	CDC42 signaling events	235
1793	68	21.7008006929955	68	0.0878	0.351510873429843	Triglyceride Biosynthesis	1793
1846	15	8.20531363086847	15	0.0878	0.351510873429843	mRNA decay by 5' to 3' exoribonuclease	991
911	27	12.059330817049	27	0.0888	0.351510873429843	Endogenous sterols	471
84	14	9.17612252836952	11	0.089	0.351510873429843	Murine Gammaherpesvirus (dsDNA)	1003
1265	33	13.4496028438641	33	0.089	0.351510873429843	Negative regulation of FGFR2 signaling	1030
1623	500	79.0235108765589	500	0.0893	0.351510873429843	Signaling by Interleukins	1535
646	17	10.6291115704823	17	0.0898	0.351510873429843	Acyl chain remodelling of PI	51
1129	27	12.5506223979872	27	0.0903	0.351510873429843	Interleukin-7 signaling	832
1255	21	9.94282280762729	21	0.0908	0.351510873429843	NOTCH2 Activation and Transmission of Signal to the Nucleus	1082
1670	19	9.29852056345053	19	0.0908	0.351510873429843	Syndecan interactions	1637
1118	196	45.4460721495485	196	0.0917	0.351510873429843	Interferon Signaling	823
905	14	7.74371051577017	14	0.0921	0.351510873429843	Early Phase of HIV Life Cycle	455
342	100	25.5840315566897	100	0.0922	0.351510873429843	Pyrimidine metabolism (KEGG)	1291
1104	14	7.82518840047548	14	0.0922	0.351510873429843	InlB-mediated entry of Listeria monocytogenes into host cell	799
1617	40	14.8550905150348	40	0.0926	0.351510873429843	Signaling by FGFR4	1528
1054	28	12.0312401448111	28	0.0928	0.351510873429843	HS-GAG biosynthesis	745
1176	86	24.2187627048529	86	0.093	0.351510873429843	MAPK6/MAPK4 signaling	915
1363	26	12.9335568832082	26	0.093	0.351510873429843	Phase 2 - plateau phase	1174
1187	86	30.8194363479012	86	0.0935	0.352134047599411	Meiotic recombination	920
414	30	12.1819543677857	30	0.0942	0.353503308334538	beta-Alanine metabolism	176
1287	43	15.3743612349689	43	0.0954	0.355840089174442	Non-integrin membrane-ECM interactions	1067
1146	32	13.1765212985348	32	0.0955	0.355840089174442	Keratan sulfate/keratin metabolism	862
1344	64	21.49210033938	64	0.0973	0.361265937906197	PKMTs methylate histone lysines	1211
662	24	11.4287875045006	24	0.0984	0.363523646459564	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	102
813	26	10.8747380104505	26	0.0986	0.363523646459564	DARPP-32 events	365
973	234	48.2287851235152	234	0.0995	0.364756321352286	G alpha (i) signalling events	588
1319	34	12.8233606270818	34	0.0999	0.364756321352286	Ovarian tumor domain proteases	1122
57	11	6.64181199360873	11	0.1	0.364756321352286	superpathway of steroid hormone biosynthesis	1632
1753	88	23.0570443153768	88	0.1007	0.364756321352286	Toll Like Receptor 9 (TLR9) Cascade*	1727
542	30	11.7263659454941	30	0.1014	0.364756321352286	Signaling events mediated by HDAC Class II	1565
138	39	13.6589765544601	39	0.1019	0.364756321352286	Bladder cancer	192
945	19	9.03823599741097	19	0.1023	0.364756321352286	FRS-mediated FGFR3 signaling	583
1103	12	6.74460926988891	12	0.1024	0.364756321352286	Initiation of Nuclear Envelope Reformation*	798
1677	31	12.7314965276329	31	0.1024	0.364756321352286	Synthesis of PA	1655
1655	451	69.2034695149027	451	0.1025	0.364756321352286	Signalling by NGF	1577
177	94	23.3038572247007	94	0.1031	0.364756321352286	Endocrine resistance	469
457	69	20.0190423741734	69	0.1031	0.364756321352286	E2F transcription factor network	452
1145	12	7.31175461923712	12	0.1045	0.368290660296128	Keratan sulfate degradation	861
1620	132	29.9078611290381	132	0.1048	0.368290660296128	Signaling by Hedgehog	1531
1647	33	12.5664317679529	33	0.1053	0.368814279650938	Signaling by WNT in cancer	1562
927	252	45.1258136493629	252	0.1075	0.371197359833402	FCERI mediated MAPK activation	538
171	28	11.0144292338258	28	0.1078	0.371197359833402	Dorso-ventral axis formation	431
483	40	13.4953047042098	40	0.1079	0.371197359833402	IFN-gamma pathway	762
273	10	6.09523420577845	10	0.108	0.371197359833402	Methionine degradation	953
902	74	26.9408928561698	74	0.1081	0.371197359833402	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	504
946	21	9.67516411976323	21	0.1081	0.371197359833402	FRS-mediated FGFR4 signaling	584
1053	32	12.324264453096	32	0.1092	0.373753160703086	HIV elongation arrest and recovery*	732
1001	16	7.85364791510313	16	0.11	0.374845403855324	GRB2 events in ERBB2 signaling	686
1002	15	7.91763526573164	15	0.112	0.374845403855324	GRB2:SOS provides linkage to MAPK signaling for Integrins	687
1497	21	10.145139779243	21	0.1121	0.374845403855324	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1344
1048	37	13.0876583109727	37	0.1122	0.374845403855324	HDR through Single Strand Annealing (SSA)	701
152	176	38.5763239009858	176	0.1124	0.374845403855324	Chemokine signaling pathway	267
464	26	9.92043459109551	26	0.1129	0.374845403855324	Ephrin B reverse signaling	487
505	22	9.13488467609486	22	0.1131	0.374845403855324	Nectin adhesion pathway	1024
1528	10	5.90584096309298	10	0.1131	0.374845403855324	Removal of the Flap Intermediate from the C-strand	1375
395	169	34.3077915078077	169	0.1134	0.374845403855324	Transcriptional misregulation in cancer	1758
490	51	15.6414578101945	51	0.1136	0.374845403855324	IL2-mediated signaling events	773
256	29	13.2597537934937	29	0.1138	0.374845403855324	Linoleic acid metabolism	882
1078	23	9.74229936369156	23	0.1138	0.374845403855324	IKK complex recruitment mediated by RIP1	765
1628	108	25.4091678405967	108	0.1146	0.375733634107621	Signaling by NOTCH	1541
83	79	20.4507710629996	77	0.1151	0.375733634107621	Kaposi's Sarcoma-associated Virus (dsDNA)	859
559	15	7.50896560688553	15	0.1153	0.375733634107621	Syndecan-3-mediated signaling events	1640
1660	13	6.79502775380627	13	0.1155	0.375733634107621	Sodium/Calcium exchangers	1592
1481	16	7.89078017352312	16	0.1162	0.375957471611558	Recycling of bile acids and salts	1315
1700	14	7.34581867025894	14	0.1165	0.375957471611558	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1688
243	96	23.7137334624986	96	0.117	0.375957471611558	Inflammatory mediator regulation of TRP channels	787
725	12	6.70940494162642	12	0.117	0.375957471611558	CS/DS degradation	340
1268	38	12.8458091821791	38	0.1185	0.378907876011928	Negative regulation of MAPK pathway	1033
1128	11	6.05774178416476	11	0.1187	0.378907876011928	Interleukin-6 signaling	831
1613	39	13.1442123914703	39	0.119	0.378907876011928	Signaling by FGFR3	1524
1641	396	63.3342441408667	396	0.1201	0.381255067404117	Signaling by Rho GTPases	1554
474	55	15.9794302950785	55	0.1208	0.38232215169939	Fc-epsilon receptor I signaling in mast cells	536
1250	12	6.22546512767502	12	0.1225	0.385276075608767	NF-kB is activated and signals survival	1054
1296	23	9.24532566244073	23	0.1234	0.385276075608767	Nuclear Events (kinase and transcription factor activation)	1089
648	763	100.928150447287	763	0.1239	0.385276075608767	Adaptive Immune System	54
408	49	14.6909478237824	49	0.1245	0.385276075608767	Vibrio cholerae infection	1841
585	66	18.8587868330767	66	0.1247	0.385276075608767	ABC transporter disorders	8
819	71	20.788539732985	71	0.1248	0.385276075608767	DNA Double Strand Break Response*	421
951	230	40.7317150037512	230	0.1249	0.385276075608767	Fatty acid, triacylglycerol, and ketone body metabolism	529
481	42	13.4113871662073	42	0.1251	0.385276075608767	Hedgehog signaling events mediated by Gli proteins	705
486	28	11.0654948307802	28	0.1252	0.385276075608767	IL12 signaling mediated by STAT4	769
127	28	10.1554028362398	28	0.1254	0.385276075608767	Autophagy - other	158
196	13	6.73942234470577	13	0.1271	0.388839675673859	Folate biosynthesis	560
1485	10	5.60410654996885	10	0.1273	0.388839675673859	Regulated proteolysis of p75NTR	1320
1804	83	19.7537782694254	83	0.1277	0.388930868420866	Unfolded Protein Response (UPR)	1819
1075	16	7.74793781503907	16	0.1292	0.392362078050337	Hyaluronan metabolism	758
663	37	12.3636081743795	37	0.1298	0.392377054337297	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	101
659	97	28.2930139253072	97	0.1307	0.392377054337297	Amyloid fiber formation	95
1257	54	15.4190106814741	54	0.1311	0.392377054337297	NRAGE signals death through JNK	1084
418	78	18.8940303654767	78	0.132	0.392377054337297	mRNA surveillance pathway	996
100	66	16.9517938180072	66	0.1321	0.392377054337297	Adipocytokine signaling pathway	62
1740	58	16.3530746279764	58	0.1321	0.392377054337297	The role of GTSE1 in G2/M progression after G2 checkpoint	1699
1099	11	5.87741116536307	11	0.1323	0.392377054337297	Inhibition of replication initiation of damaged DNA by RB1/E2F1	794
1386	106	28.722268984731	106	0.133	0.392377054337297	Positive epigenetic regulation of rRNA expression	1230
1186	117	30.6177046977191	117	0.1332	0.392377054337297	Meiosis	919
557	16	7.13032419248543	16	0.1333	0.392377054337297	Syndecan-1-mediated signaling events	1638
1364	19	8.25789623104731	19	0.1338	0.392377054337297	Phase 4 - resting membrane potential	1175
261	51	14.5767326991513	51	0.1339	0.392377054337297	Lysine degradation	897
775	65	17.0903106018827	65	0.1341	0.392377054337297	Cleavage of Growing Transcript in the Termination Region*	301
1638	67	17.3462453479768	67	0.1346	0.392377054337297	Signaling by PTK6	1551
550	52	14.5429986753936	52	0.1355	0.392377054337297	Signaling events mediated by focal adhesion kinase	1563
503	30	10.2377903766425	30	0.1356	0.392377054337297	Lissencephaly gene (LIS1) in neuronal migration and development	885
514	54	15.3418761828173	54	0.1358	0.392377054337297	PDGFR-beta signaling pathway	1158
416	191	34.0541200190995	191	0.1361	0.392377054337297	cAMP signaling pathway	214
1608	49	14.4902056758175	49	0.1363	0.392377054337297	Signaling by FGFR1	1519
1323	92	21.8352217151404	92	0.1373	0.394032350054421	PCP/CE pathway	1155
1429	257	42.7132827491721	257	0.1379	0.394032350054421	RET signaling	1391
1282	455	64.9419932897803	455	0.1386	0.394032350054421	Neutrophil degranulation	1051
1256	12	6.09224216907852	12	0.1391	0.394032350054421	NOTCH2 intracellular domain regulates transcription	1083
1330	17	7.19849072733104	17	0.1397	0.394032350054421	PI-3K cascade:FGFR3	1195
1403	93	22.7208540777817	93	0.1401	0.394032350054421	Processing of DNA double-strand break ends	1255
1728	12	5.99049024508201	12	0.1403	0.394032350054421	Tandem pore domain potassium channels	1671
1314	320	49.6180864531417	320	0.1407	0.394032350054421	Organelle biogenesis and maintenance	1112
306	148	29.8792029164711	148	0.1408	0.394032350054421	Oxytocin signaling pathway	1126
1130	172	32.1858367043347	172	0.1415	0.394032350054421	Intra-Golgi and retrograde Golgi-to-ER traffic	835
562	46	13.7011670397455	46	0.1419	0.394032350054421	TCR signaling in naive CD8+ T cells	1681
903	20	8.06418657935413	20	0.142	0.394032350054421	ERK/MAPK targets	505
1741	28	9.79294205247994	28	0.1428	0.394032350054421	The role of Nef in HIV-1 replication and disease pathogenesis	1700
1707	96	22.6709940851338	96	0.1429	0.394032350054421	TNFR2 non-canonical NF-kB pathway	1719
1251	370	54.3615138915845	370	0.1434	0.394032350054421	NGF signalling via TRKA from the plasma membrane	1055
644	29	11.5833697812978	29	0.144	0.394032350054421	Acyl chain remodelling of PE	49
1818	93	21.6047621064446	93	0.1447	0.394032350054421	Visual phototransduction	1847
162	27	9.71292778789565	27	0.1448	0.394032350054421	Collecting duct acid secretion	310
768	18	7.33108343420384	18	0.1451	0.394032350054421	Citric acid cycle (TCA cycle)	292
930	15	6.98770931880664	15	0.1452	0.394032350054421	FGFR1 ligand binding and activation	545
1039	108	23.0019747822664	108	0.1454	0.394032350054421	Golgi-to-ER retrograde transport	680
1437	11	5.45648312382707	11	0.1455	0.394032350054421	RHO GTPases activate KTN1	1407
1525	11	5.71910735102324	11	0.1464	0.394032350054421	Regulation of signaling by NODAL	1361
1175	10	5.23682269946942	10	0.1465	0.394032350054421	MAPK3 (ERK1) activation	914
1582	111	23.1116892202092	111	0.1468	0.394032350054421	Selenoamino acid metabolism	1478
1656	250	45.8958785836124	290	0.1478	0.394032350054421	Signalling to ERKs*	1578
1042	91	26.048410230893	91	0.1481	0.394032350054421	HDACs deacetylate histones	695
1197	758	94.1508854529357	758	0.1483	0.394032350054421	Metabolism of lipids and lipoproteins	939
119	61	17.19114573	61	0.1485	0.394032350054421	Arachidonic acid metabolism (KEGG)	125
851	108	24.9156204889907	108	0.1486	0.394032350054421	Degradation of the extracellular matrix	391
202	74	17.9141238205695	74	0.15	0.394032350054421	Gastric acid secretion	623
337	22	8.22623773166903	22	0.1501	0.394032350054421	Protein export	1269
1433	17	7.03644921721415	17	0.1504	0.394032350054421	RHO GTPases Activate ROCKs	1411
1560	17	7.12918548366376	17	0.1504	0.394032350054421	SHC-mediated cascade:FGFR3	1494
869	41	12.3044473076403	41	0.1507	0.394032350054421	Diseases of metabolism	414
94	93	20.5921938607153	93	0.1508	0.394032350054421	AGE-RAGE signaling pathway in diabetic complications	70
1863	42	12.5744744732575	42	0.1509	0.394032350054421	tRNA Aminoacylation	1797
1331	19	7.8354188496833	19	0.152	0.394032350054421	PI-3K cascade:FGFR4	1196
161	47	12.7203066404925	47	0.1521	0.394032350054421	Cocaine addiction	305
309	61	15.1186732086039	61	0.1522	0.394032350054421	Pancreatic cancer	1142
1610	73	17.3816783876004	73	0.1524	0.394032350054421	Signaling by FGFR2	1521
164	76	19.9451197840106	76	0.1528	0.394032350054421	Complement and coagulation cascades	313
967	90	24.8572230721088	90	0.1537	0.394032350054421	Formation of the beta-catenin:TCF transactivating complex	570
1792	159	29.0222154972997	159	0.1539	0.394032350054421	Transport to the Golgi and subsequent modification	1787
1667	24	8.82220836883731	24	0.1542	0.394032350054421	Sulfur amino acid metabolism	1613
1724	16	6.62349210089248	16	0.1542	0.394032350054421	TRAF6 mediated induction of TAK1 complex	1746
1162	19	7.4815983155254	19	0.1545	0.394032350054421	Listeria monocytogenes entry into host cells	886
604	53	14.5755235292976	53	0.1554	0.39466686269541	AUF1 (hnRNP D0) binds and destabilizes mRNA	150
681	64	16.5991867899387	64	0.1555	0.39466686269541	Asymmetric localization of PCP proteins	143
1111	27	9.39602830269784	27	0.1565	0.395508126646385	Integrin alphaIIb beta3 signaling	813
1061	10	5.00860261140826	10	0.1571	0.395508126646385	Heme biosynthesis	708
1561	19	7.76611360601602	19	0.1588	0.395508126646385	SHC-mediated cascade:FGFR4	1495
1278	328	49.1765326123833	328	0.1594	0.395508126646385	Neuronal System	1045
675	275	42.3835667190544	275	0.1608	0.395508126646385	Asparagine N-linked glycosylation	136
1243	15	6.2192598219752	15	0.161	0.395508126646385	N-Glycan antennae elongation	1013
1371	192	33.5679556380582	192	0.1615	0.395508126646385	Phospholipid metabolism	1186
699	215	41.4505895679673	215	0.1616	0.395508126646385	Biological oxidations	187
495	43	12.0533445114795	43	0.1624	0.395508126646385	Insulin Pathway	804
1211	25	8.98585263334349	25	0.1624	0.395508126646385	MicroRNA (miRNA) biogenesis	958
1855	88	19.2422818116225	88	0.1624	0.395508126646385	p75 NTR receptor-mediated signalling	1137
1398	12	6.14175510011694	12	0.1625	0.395508126646385	Presynaptic nicotinic acetylcholine receptors	1247
529	71	16.549643103712	71	0.1628	0.395508126646385	Regulation of Wnt-mediated beta catenin signaling and target gene transcription	1372
787	64	15.893426864428	64	0.1629	0.395508126646385	Constitutive Signaling by Aberrant PI3K in Cancer	318
352	53	13.521181271949	53	0.1631	0.395508126646385	Regulation of lipolysis in adipocytes	1347
105	81	18.1987532105142	81	0.1633	0.395508126646385	Aldosterone synthesis and secretion	74
1535	26	8.97571742219206	26	0.1637	0.395508126646385	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1385
364	15	6.28059763347728	15	0.1641	0.395508126646385	Selenocompound metabolism	1479
1430	278	45.4619454353187	278	0.1642	0.395508126646385	RHO GTPase Effectors	1403
751	190	37.3492149426607	190	0.1645	0.395508126646385	Cellular Senescence	256
248	82	18.1549142958748	82	0.1651	0.395508126646385	Insulin secretion	809
1367	16	6.78936925117498	16	0.1651	0.395508126646385	Phospholipase C-mediated cascade: FGFR1	1183
1110	107	21.5276456347963	107	0.1654	0.395508126646385	Integration of energy metabolism	812
20	13	5.635704314411	13	0.1657	0.395508126646385	fatty acid beta-oxidation (peroxisome)	524
639	12	5.68919116795107	12	0.1658	0.395508126646385	Activation of the TFAP2 (AP-2) family of transcription factors	46
1288	63	17.0351067042444	63	0.1659	0.395508126646385	Nonhomologous End-Joining (NHEJ)	1071
1605	43	11.9394029078189	43	0.1668	0.395508126646385	Signaling by ERBB4	1516
736	31	9.91147604452262	31	0.1671	0.395508126646385	Cargo concentration in the ER	222
989	90	20.6506680657441	90	0.1673	0.395508126646385	G2/M DNA damage checkpoint	604
58	30	9.87841699666931	30	0.1675	0.395508126646385	superpathway of tryptophan utilization	1633
1125	258	39.6838917216865	258	0.1675	0.395508126646385	Interleukin-3, 5 and GM-CSF signaling	828
223	24	8.37814350115567	24	0.1687	0.395791169759488	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	673
1127	27	8.94075170260183	27	0.1692	0.395791169759488	Interleukin-6 family signaling	830
429	43	11.8676357178267	43	0.1696	0.395791169759488	Arf6 trafficking events	130
293	12	5.31744661657037	12	0.1697	0.395791169759488	Non-homologous end-joining	1066
1518	122	23.1467545509294	122	0.1701	0.395791169759488	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)*	1346
1719	13	5.5360275523908	13	0.1702	0.395791169759488	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	1743
871	72	17.1735756011011	72	0.1708	0.395791169759488	Disorders of transmembrane transporters	416
4	16	6.44586442538876	16	0.1712	0.395791169759488	CDP-diacylglycerol biosynthesis	239
1787	100	20.9074829385244	100	0.1715	0.395791169759488	Transport of inorganic cations/anions and amino acids/oligopeptides	1777
1646	322	46.0149520058988	322	0.1717	0.395791169759488	Signaling by VEGF*	1560
853	14	5.76884059587309	14	0.1723	0.395791169759488	Depolymerisation of the Nuclear Lamina	394
189	21	7.76013210542091	21	0.1727	0.395791169759488	Fatty acid elongation	527
436	77	17.1385854730348	77	0.1728	0.395791169759488	C-MYB transcription factor network	201
570	22	7.50444143338348	22	0.1732	0.395791169759488	VEGFR3 signaling in lymphatic endothelium	1839
1564	14	5.9132299853532	14	0.1738	0.395791169759488	SHC1 events in ERBB4 signaling	1498
211	35	10.6383140307033	35	0.1744	0.395791169759488	Glycine, serine and threonine metabolism	654
1173	29	9.12499568649011	29	0.1744	0.395791169759488	MAPK targets/ Nuclear events mediated by MAP kinases	912
1300	25	8.37407535623527	25	0.1744	0.395791169759488	Nuclear signaling by ERBB4	1093
838	59	14.7440473446821	59	0.1754	0.397202725284744	Defective CFTR causes cystic fibrosis	378
453	128	23.8733497522009	128	0.1762	0.397274034636429	Direct p53 effectors	406
1689	15	5.96979749459631	15	0.1764	0.397274034636429	Synthesis of glycosylphosphatidylinositol (GPI)	1651
1123	46	12.909869415984	46	0.1771	0.397274034636429	Interleukin-10 signaling	826
860	17	7.53988673036401	17	0.1775	0.397274034636429	Digestion of dietary lipid	403
863	803	92.1066058517478	803	0.1777	0.397274034636429	Disease	408
1208	34	10.4032024282593	34	0.1777	0.397274034636429	Metalloprotease DUBs	951
375	18	6.75601190152743	18	0.1787	0.397832242738384	Steroid biosynthesis	1608
1426	24	7.82517301229896	24	0.1791	0.397832242738384	RAF activation	1301
484	27	8.57144886534594	27	0.1795	0.397832242738384	IGF1 pathway	763
1587	64	14.7557143580146	64	0.1796	0.397832242738384	Semaphorin interactions	1485
434	63	14.6287484592013	63	0.18	0.397832242738384	BCR signaling pathway	174
29	18	6.88122753007279	18	0.1803	0.397832242738384	heparan sulfate biosynthesis (late stages)	711
1178	20	7.38099184410493	20	0.1806	0.397832242738384	MET activates PTK2 signaling	927
95	117	21.6246755235415	117	0.1812	0.398318894448318	AMPK signaling pathway	94
1310	32	9.67963098060575	32	0.182	0.399111353319156	Oncogene Induced Senescence	1106
900	13	5.43656736302881	13	0.1825	0.399111353319156	ERBB2 Activates PTK6 Signaling	500
1626	68	15.2351181510078	68	0.1827	0.399111353319156	Signaling by MET	1538
200	29	8.89775896375063	29	0.1838	0.400545281460279	Galactose metabolism	612
1739	34	9.62284852022771	34	0.1843	0.400545281460279	The phototransduction cascade*	1698
870	351	48.5190367088185	351	0.1845	0.400545281460279	Diseases of signal transduction	415
950	46	12.1471435717999	46	0.1854	0.400842785734374	Fatty Acyl-CoA Biosynthesis	531
1034	116	22.472080541273	116	0.1854	0.400842785734374	Glycosaminoglycan metabolism	668
1779	635	76.1691109155964	635	0.1859	0.401098501711797	Transmembrane transport of small molecules	1774
1180	11	4.75108046035087	11	0.187	0.401446937286628	MET activates RAS signaling	929
827	39	10.4389443073299	39	0.1874	0.401446937286628	Deactivation of the beta-catenin transactivating complex	367
698	41	11.244555137136	41	0.1879	0.401446937286628	Binding and Uptake of Ligands by Scavenger Receptors	186
424	30	8.82076361769115	30	0.1884	0.401446937286628	Alpha-synuclein signaling	82
444	22	7.45724680453368	22	0.1885	0.401446937286628	Canonical NF-kappaB pathway	215
74	52	13.2921913838933	49	0.1886	0.401446937286628	Human Cytomegalovirus (dsDNA)	750
180	64	14.1832707037883	64	0.1889	0.401446937286628	Epithelial cell signaling in Helicobacter pylori infection	490
1726	10	4.40205878615038	10	0.1893	0.401446937286628	TRIF-mediated programmed cell death	1791
1477	29	8.63907487921123	29	0.1895	0.401446937286628	Recognition of DNA damage by PCNA-containing replication complex	1311
1284	26	8.23273910667153	26	0.1899	0.401462973388781	Nicotinate metabolism	1058
303	20	6.88707747568791	20	0.1906	0.401462973388781	Other types of O-glycan biosynthesis	1120
506	25	7.77009489367753	25	0.1912	0.401462973388781	Nephrin/Neph1 signaling in the kidney podocyte	1040
1509	36	9.88548617691792	36	0.1915	0.401462973388781	Regulation of TP53 Expression and Degradation*	1371
72	161	28.2284666014329	145	0.1918	0.401462973388781	Hepatitis C Virus (ssRNA)	718
1427	22	7.33737991044857	22	0.1918	0.401462973388781	RAF-independent MAPK1/3 activation	1302
1320	123	26.1906912539713	123	0.1925	0.401537728150696	Oxidative Stress Induced Senescence	1124
264	244	37.1786914902367	244	0.1926	0.401537728150696	MAPK signaling pathway	911
884	26	8.16593604098724	26	0.1938	0.402099154071283	Downstream signaling of activated FGFR4	442
1579	20	6.92220016931483	20	0.1939	0.402099154071283	Scavenging by Class A Receptors	1474
711	11	4.59408112220686	11	0.1943	0.402099154071283	CD28 dependent Vav1 pathway	232
1643	323	44.8618874715648	323	0.1944	0.402099154071283	Signaling by SCF-KIT	1556
643	27	8.9019846054347	27	0.1956	0.402276561666996	Acyl chain remodelling of PC	48
628	31	9.70541832058479	31	0.1959	0.402276561666996	Activation of Matrix Metalloproteinases	34
341	162	26.2562029200683	162	0.1964	0.402276561666996	Purine metabolism (KEGG)	1281
1119	68	17.3954849237408	68	0.1964	0.402276561666996	Interferon alpha/beta signaling	821
1402	29	8.45144321981605	29	0.1964	0.402276561666996	Processing of Capped Intronless Pre-mRNA	1254
883	24	7.52900791863498	24	0.1972	0.403129335567999	Downstream signaling of activated FGFR3	441
1472	27	8.05843215528311	27	0.1977	0.403256517027705	RORA activates gene expression	1456
1358	83	16.8418373272283	83	0.1992	0.403256517027705	Peptide hormone metabolism	1165
237	21	7.14458567486134	21	0.1995	0.403256517027705	Histidine metabolism	730
872	13	5.05034395192813	13	0.2002	0.403256517027705	Dissolution of Fibrin Clot	417
881	31	9.00209179024714	31	0.2004	0.403256517027705	Downstream signaling of activated FGFR1	439
274	11	4.47542818748323	11	0.2005	0.403256517027705	Methionine salvage pathway	954
1679	12	4.84364080034955	12	0.2006	0.403256517027705	Synthesis of PE	1657
944	24	7.579758554299	24	0.2007	0.403256517027705	FRS-mediated FGFR2 signaling	582
688	45	10.8679554964872	45	0.201	0.403256517027705	BMAL1:CLOCK,NPAS2 activates circadian gene expression	193
463	52	12.0133016367522	52	0.2011	0.403256517027705	Endothelins	475
1169	58	12.9338596136484	58	0.2015	0.403288983039827	MAP kinase activation in TLR cascade	907
1832	17	5.78459903777184	17	0.2021	0.403385643212279	Zinc transporters	1868
133	32	8.78951925926748	32	0.2025	0.403385643212279	Base excision repair	169
690	10	4.15907063645814	10	0.2027	0.403385643212279	Base-Excision Repair, AP Site Formation	171
1205	164	26.9978560536695	164	0.2037	0.404242496483504	Metabolism of vitamins and cofactors	947
488	36	9.29688030034258	36	0.2039	0.404242496483504	IL2 signaling events mediated by PI3K	771
1136	190	31.0710991080286	190	0.2049	0.404332883032704	Ion channel transport	841
197	127	21.7043405761185	127	0.205	0.404332883032704	FoxO signaling pathway	580
1563	22	6.88423223934456	22	0.2051	0.404332883032704	SHC1 events in ERBB2 signaling	1497
1312	83	16.6285662507854	83	0.2056	0.404559556410432	Opioid Signalling	1110
210	86	17.6330659763033	86	0.2061	0.404785382411046	Glycerophospholipid metabolism	653
1333	16	5.56010031296325	16	0.2067	0.405206401772382	PI3K events in ERBB2 signaling	1198
1399	39	10.0515017806953	39	0.2073	0.405625853091404	Presynaptic phase of homologous DNA pairing and strand exchange	1248
1820	43	10.9152253662052	43	0.2079	0.406007843046271	Voltage gated Potassium channels	1854
785	71	18.4295526059011	71	0.2086	0.406007843046271	Condensation of Prophase Chromosomes	317
1067	11	4.71702326494261	11	0.2092	0.406007843046271	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	727
1690	62	13.6275229929871	62	0.2099	0.406007843046271	Synthesis of substrates in N-glycan biosythesis	1662
441	73	14.8845134408785	73	0.21	0.406007843046271	CXCR4-mediated signaling events	343
1010	25	7.46873142986641	25	0.21	0.406007843046271	Gap-filling DNA repair synthesis and ligation in GG-NER	621
560	31	8.22026917361083	31	0.2102	0.406007843046271	Syndecan-4-mediated signaling events	1641
816	47	11.0286396372184	47	0.2109	0.406612465450654	DNA Damage Bypass	418
1063	49	11.4349649560686	49	0.212	0.406712201027636	Heparan sulfate/heparin (HS-GAG) metabolism	712
1691	22	6.87048654757299	22	0.212	0.406712201027636	Synthesis of very long-chain fatty acyl-CoAs	1663
1425	56	12.4079704860788	56	0.2122	0.406712201027636	RAB geranylgeranylation	1299
535	40	9.82758078528407	40	0.2125	0.406712201027636	RhoA signaling pathway	1413
1082	52	11.3572838131029	52	0.2134	0.407692138189641	IRE1alpha activates chaperones*	847
1080	15	5.21470793724162	15	0.2147	0.409431315458847	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	845
932	11	4.43820846622623	11	0.2155	0.410212422399651	FGFR1c ligand binding and activation*	547
257	56	12.4034962705947	56	0.2163	0.410834930747432	Long-term depression	888
104	170	29.5457191507747	170	0.2169	0.410834930747432	Alcoholism	73
319	74	15.3421481316113	74	0.217	0.410834930747432	Pertussis	1170
1597	20	6.26657039701761	20	0.218	0.411985862407021	Signal transduction by L1	1505
1588	107	22.4374527569677	107	0.2194	0.413887241660993	Senescence-Associated Secretory Phenotype (SASP)	1487
88	25	7.38453621660969	23	0.2198	0.413898736162302	Simian Virus 40 (dsDNA)	1581
1606	86	16.0758249126878	86	0.2208	0.414328865421345	Signaling by FGFR	1517
467	35	8.7273167400154	35	0.2209	0.414328865421345	ErbB2/ErbB3 signaling events	502
232	139	23.3698743101903	139	0.2218	0.414328865421345	Hepatitis B	713
1546	128	20.7777105017611	128	0.2219	0.414328865421345	Rho GTPase cycle	1402
362	86	16.5740311144153	86	0.222	0.414328865421345	Salivary secretion	1470
948	151	25.5428844173222	151	0.2226	0.414712062043093	Factors involved in megakaryocyte development and platelet production	518
269	101	17.7570445887736	101	0.2234	0.415465850157676	Melanogenesis	922
1727	24	7.18226569634589	24	0.2247	0.417145201683055	TRP channels	1801
409	194	29.2362251497343	194	0.2269	0.419064993469643	Viral carcinogenesis	1843
999	50	11.0998554902263	50	0.2271	0.419064993469643	GPVI-mediated activation cascade	683
499	13	4.60734035552391	13	0.228	0.419064993469643	JNK signaling in the CD4+ TCR pathway	857
721	66	13.2432792406743	66	0.2282	0.419064993469643	COPII (Coat Protein 2) Mediated Vesicle Transport	331
684	49	11.7168537791187	54	0.2296	0.419064993469643	Autodegradation of the E3 ubiquitin ligase COP1*	155
37	11	4.2799467650368	11	0.2301	0.419064993469643	purine deoxyribonucleosides salvage	1280
39	10	3.84304278285883	10	0.2301	0.419064993469643	purine nucleotides degradation	1284
53	27	7.43581014687947	27	0.2309	0.419064993469643	superpathway of purine nucleotide salvage	1628
1586	24	6.55034996018886	24	0.2313	0.419064993469643	Sema4D induced cell migration and growth-cone collapse	1484
1401	229	31.6692286447992	229	0.2318	0.419064993469643	Processing of Capped Intron-Containing Pre-mRNA	1253
898	128	20.6271569798159	128	0.2319	0.419064993469643	ER to Golgi Anterograde Transport	495
664	93	16.7867890194974	93	0.2325	0.419064993469643	Antigen processing-Cross presentation	104
420	65	12.6033277982181	65	0.2327	0.419064993469643	p53 signaling pathway	1132
8	15	4.84803590658989	15	0.2328	0.419064993469643	D-myo-inositol-5-phosphate metabolism	361
1774	17	5.39346566950693	17	0.2332	0.419064993469643	Translesion synthesis by POLK	1769
767	67	13.0775189670218	67	0.2334	0.419064993469643	Circadian Clock	285
1181	31	8.18719646098539	31	0.2337	0.419064993469643	MET promotes cell motility	930
928	74	14.2175129667831	74	0.234	0.419064993469643	FCERI mediated NF-kB activation	539
988	161	25.0741506446215	161	0.2347	0.419064993469643	G2/M Checkpoints	603
1060	63	12.9901200673593	63	0.235	0.419064993469643	Hedgehog ligand biogenesis	704
1070	133	22.1368703592627	133	0.235	0.419064993469643	Homology Directed Repair*	740
1529	12	4.41774569718541	12	0.2351	0.419064993469643	Repression of WNT target genes	1379
216	23	6.62809664521757	23	0.2356	0.419064993469643	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	664
524	46	10.2816090973808	46	0.2356	0.419064993469643	Regulation of Androgen receptor activity	1325
390	112	18.4157969519285	112	0.2365	0.419064993469643	Thyroid hormone signaling pathway	1707
955	26	6.96011464540561	26	0.2365	0.419064993469643	Fertilization*	543
1710	11	4.0856070565001	11	0.237	0.419064993469643	TP53 Regulates Transcription of Caspase Activators and Caspases	1735
626	18	5.51412331068311	18	0.2372	0.419064993469643	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	32
1044	45	10.9463702805429	45	0.2373	0.419064993469643	HDMs demethylate histones	697
10	15	4.78590008719239	15	0.2386	0.420653775046912	TCA cycle	1677
820	161	25.0995957723709	161	0.2401	0.42205535191138	DNA Double-Strand Break Repair	422
382	105	17.6116617957694	105	0.2406	0.42205535191138	TNF signaling pathway	1716
1762	344	41.8708676054846	344	0.2406	0.42205535191138	Transcriptional Regulation by TP53	1761
422	11	3.87238253039237	11	0.2416	0.422399182576364	ALK2 signaling events	77
610	14	5.03128363283999	14	0.2416	0.422399182576364	Acetylcholine Binding And Downstream Events*	13
1216	14	4.62247806915064	14	0.2427	0.423606522023185	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	966
367	136	20.9568190832993	136	0.2435	0.423606522023185	Signaling pathways regulating pluripotency of stem cells	1576
1849	15	4.94353054501686	15	0.2435	0.423606522023185	p130Cas linkage to MAPK signaling for integrins	1127
445	29	7.27255274520345	29	0.2446	0.424787146506397	Canonical Wnt signaling pathway	216
460	17	5.16857549984839	17	0.2452	0.424787146506397	EPHA2 forward signaling	484
582	54	10.9080757050789	54	0.246	0.424787146506397	p53 pathway	1131
1507	89	15.3177955626078	89	0.246	0.424787146506397	Regulation of TP53 Activity through Phosphorylation	1369
565	24	6.93348619267179	24	0.2462	0.424787146506397	TRAIL signaling pathway	1752
98	20	5.8883426576077	20	0.247	0.42510069739422	Adenine ribonucleotide biosynthesis, IMP => ADP,ATP	55
1443	77	15.6110793462098	77	0.2477	0.42510069739422	RMTs methylate histone arginines	1421
563	50	10.5626919565747	50	0.2478	0.42510069739422	TGF-beta receptor signaling	1689
1126	104	17.3351098072593	104	0.248	0.42510069739422	Interleukin-4 and 13 signaling	829
1635	11	3.82858026630045	11	0.2491	0.425239882479045	Signaling by NOTCH3	1548
508	29	6.88937367720578	29	0.2495	0.425239882479045	Noncanonical Wnt signaling pathway	1069
1206	116	18.6647014959617	116	0.2495	0.425239882479045	Metabolism of water-soluble vitamins and cofactors	948
1850	13	4.50371214195657	13	0.2497	0.425239882479045	p38MAPK events	1130
1423	21	5.82305158924252	21	0.2511	0.426232843177148	RA biosynthesis pathway	1297
208	51	11.5924273610059	51	0.2514	0.426232843177148	Glutathione metabolism	648
86	10	3.78334431503759	9	0.2515	0.426232843177148	Polyomavirus (dsDNA)	1228
650	15	4.65886361108371	15	0.2528	0.426531599439252	Adenylate cyclase inhibitory pathway*	59
330	34	8.32344452217392	34	0.2531	0.426531599439252	Prion diseases	1251
749	54	11.2924617243661	54	0.2531	0.426531599439252	Cell-cell junction organization	250
370	117	18.1994602414398	117	0.2533	0.426531599439252	Sphingolipid signaling pathway	1597
1069	42	9.0671918891918	42	0.254	0.427025992165644	Homologous DNA Pairing and Strand Exchange	738
435	33	7.74522894589872	33	0.2553	0.428525916800399	BMP receptor signaling	194
754	427	51.0605074990625	427	0.2563	0.428757307282267	Cellular responses to stress	254
1326	28	6.89040764485773	28	0.2572	0.428757307282267	PERK regulates gene expression	1167
157	30	6.92220014665942	30	0.2577	0.428757307282267	Circadian rhythm	287
284	85	14.7327351562739	85	0.2581	0.428757307282267	NF-kappa B signaling pathway	1052
581	20	5.57404622709966	20	0.2581	0.428757307282267	p38 signaling mediated by MAPKAP kinases	1129
621	11	3.71457096196096	11	0.2582	0.428757307282267	Activation of Ca-permeable Kainate Receptor*	26
987	17	4.82481482592335	17	0.2588	0.428757307282267	G1/S-Specific Transcription	602
1144	27	6.79917796061732	27	0.259	0.428757307282267	Keratan sulfate biosynthesis	860
1244	26	6.42995430560634	26	0.2606	0.428757307282267	N-glycan antennae elongation in the medial/trans-Golgi	1014
910	17	4.96103065336334	17	0.261	0.428757307282267	Elevation of cytosolic Ca2+ levels	467
1329	22	5.74001328421907	22	0.2618	0.428757307282267	PI-3K cascade:FGFR2	1194
332	70	12.3971221536621	70	0.2621	0.428757307282267	Prolactin signaling pathway	1262
1262	21	5.54157653200514	21	0.2621	0.428757307282267	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1026
1349	71	15.1309555317546	71	0.2629	0.428757307282267	PRC2 methylates histones and DNA	1240
536	51	9.98680338721078	51	0.2634	0.428757307282267	Role of Calcineurin-dependent NFAT signaling in lymphocytes	1453
287	256	33.0454910320826	256	0.2637	0.428757307282267	Neuroactive ligand-receptor interaction	1043
1734	33	7.67913420855509	33	0.2647	0.428757307282267	Termination of translesion DNA synthesis	1685
941	13	4.21352928116575	13	0.2651	0.428757307282267	FGFR4 ligand binding and activation	556
1504	29	6.75832429149378	29	0.2652	0.428757307282267	Regulation of TP53 Activity through Acetylation	1366
1568	272	33.851490753193	272	0.2653	0.428757307282267	SLC-mediated transmembrane transport	1586
947	14	4.34043295098496	14	0.267	0.428757307282267	Facilitative Na+-independent glucose transporters	517
982	47	9.45366870794971	47	0.267	0.428757307282267	G-protein mediated events*	597
1412	15	4.43949980718742	15	0.2671	0.428757307282267	Protein methylation	1271
9	11	3.58941703294399	11	0.2673	0.428757307282267	NAD de novo biosynthesis	1020
846	53	10.3974573880818	53	0.2676	0.428757307282267	Degradation of AXIN	386
512	31	6.7033484569613	31	0.2681	0.428757307282267	Osteopontin-mediated events	1117
1142	10	3.33723101537397	10	0.2681	0.428757307282267	Josephin domain DUBs	858
1414	65	11.7238544754682	65	0.2685	0.428757307282267	Protein-protein interactions at synapses	1275
498	33	7.33645361009951	33	0.2686	0.428757307282267	Internalization of ErbB1	833
294	57	10.5446265754503	57	0.2691	0.428757307282267	Non-small cell lung cancer	1068
1571	105	15.8397605271208	105	0.2696	0.428757307282267	SRP-dependent cotranslational protein targeting to membrane	1602
1519	86	14.7461477509454	86	0.2701	0.428757307282267	Regulation of mRNA stability by proteins that bind AU-rich elements	1349
268	125	20.2033338600189	125	0.2704	0.428757307282267	Measles	918
1825	13	3.83149682285795	13	0.2704	0.428757307282267	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1861
76	19	5.27570035517077	17	0.2706	0.428757307282267	Human Immunodeficiency Virus type 1 (ssRNA)	752
1041	134	21.7736655678556	134	0.2716	0.428757307282267	HATs acetylate histones	694
1559	22	5.67070804055179	22	0.2718	0.428757307282267	SHC-mediated cascade:FGFR2	1493
939	11	3.57660115881349	11	0.2719	0.428757307282267	FGFR3 mutant receptor activation*	554
693	145	21.0711202144855	145	0.2724	0.428757307282267	Beta-catenin independent WNT signaling	177
64	13	4.18269117183312	12	0.273	0.428757307282267	Chinkungunya Virus (ssRNA)	268
140	27	6.46997216283736	27	0.273	0.428757307282267	Butanoate metabolism	198
1093	361	40.8283501767354	361	0.2731	0.428757307282267	Infectious disease	784
1786	101	16.1701745392117	101	0.2733	0.428757307282267	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1776
824	63	13.8335494483788	63	0.2734	0.428757307282267	DNA methylation	423
54	15	4.47664367656419	15	0.2738	0.428757307282267	superpathway of pyrimidine deoxyribonucleoside salvage	1629
651	26	6.49086794703713	26	0.2743	0.428888307320255	Adherens junctions interactions	61
67	17	5.52131311585597	13	0.2747	0.428888307320255	Enterovirus 71 (ssRNA)	479
489	28	6.50810868815801	28	0.2764	0.430575202074283	IL2 signaling events mediated by STAT5	772
1615	21	5.39599762952064	21	0.2766	0.430575202074283	Signaling by FGFR3 in disease*	1526
533	53	9.77904667812432	53	0.2777	0.431648061578354	Regulation of retinoblastoma protein	1358
541	62	10.8162068494966	62	0.2786	0.431907428179436	Signaling events mediated by HDAC Class I	1564
1838	22	5.36262045187445	22	0.2788	0.431907428179436	eNOS activation and regulation*	478
1416	33	7.13854730862583	33	0.2791	0.431907428179436	Purine metabolism (REACTOME)	1282
110	43	8.36777171227761	43	0.2817	0.434260080974819	Aminoacyl-tRNA biosynthesis	91
1141	15	4.01195414777241	15	0.2819	0.434260080974819	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	856
329	32	7.21284042396839	32	0.282	0.434260080974819	Primary immunodeficiency	1250
465	13	3.96345429169675	13	0.2826	0.434260080974819	ErbB receptor signaling network	497
59	15	4.21535772874754	15	0.2827	0.434260080974819	the visual cycle I (vertebrates)	1701
1584	14	3.92371526739581	14	0.2831	0.434260080974819	Sema3A PAK dependent Axon repulsion	1481
1666	32	7.26911460250102	32	0.2845	0.435744516217723	Striated Muscle Contraction	1612
1664	52	9.67225078774965	52	0.2861	0.435744516217723	Stabilization of p53	1604
218	10	3.32836293223394	10	0.2864	0.435744516217723	Glycosaminoglycan biosynthesis, heparan sulfate backbone	666
671	35	7.14940609468928	35	0.2866	0.435744516217723	Apoptotic cleavage of cellular proteins	122
1406	14	3.98973196482733	14	0.2867	0.435744516217723	Processive synthesis on the lagging strand	1258
587	101	15.9424040276902	101	0.2868	0.435744516217723	ABC-family proteins mediated transport	11
502	14	3.84783783853124	14	0.2872	0.435744516217723	LPA4-mediated signaling events	895
709	31	6.44415913908041	31	0.2878	0.435744516217723	CD28 co-stimulation	230
1737	23	5.48517657674765	23	0.2878	0.435744516217723	The canonical retinoid cycle in rods (twilight vision)	1695
705	12	4.03536940932541	12	0.2885	0.436175857997891	Butyrophilin (BTN) family interactions	200
1298	48	8.86926935600542	48	0.289	0.43630401979206	Nuclear Receptor transcription pathway	1092
614	65	13.2663879842635	65	0.2896	0.436582567482584	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	17
1370	14	4.01518921353409	14	0.2902	0.436860317042189	Phospholipase C-mediated cascade; FGFR4	1182
519	46	8.66959035726154	46	0.2913	0.43788888343673	Presenilin action in Notch and Wnt signaling	1245
369	43	8.10332463188327	43	0.2933	0.440208600763553	Sphingolipid metabolism (KEGG)	1595
717	95	14.3094077599383	95	0.2939	0.440208600763553	CLEC7A (Dectin-1) signaling	303
1853	51	9.44091703247781	51	0.2941	0.440208600763553	p53-Independent DNA Damage Response*	1135
601	25	5.62184354813009	25	0.2961	0.440814468019684	ATF4 activates genes	145
697	43	8.14816011517009	43	0.2972	0.440814468019684	Bile acid and bile salt metabolism	182
727	11	3.70327674689949	11	0.2974	0.440814468019684	CYP2E1 reactions	348
1065	56	9.93019056920365	56	0.2975	0.440814468019684	Hh mutants abrogate ligand secretion*	722
1190	11	3.11960003860156	11	0.2979	0.440814468019684	Membrane binding and targetting of GAG proteins*	925
1450	109	17.0719431456948	109	0.2983	0.440814468019684	RNA Polymerase I Transcription*	1430
403	125	16.9674397890129	125	0.2984	0.440814468019684	Ubiquitin mediated proteolysis	1814
182	81	12.3315041880666	81	0.2986	0.440814468019684	ErbB signaling pathway	498
649	10	2.90655200582776	10	0.2987	0.440814468019684	Adenylate cyclase activating pathway	58
1196	16	4.12896024190153	16	0.2987	0.440814468019684	Metabolism of folate and pterines	938
882	29	6.07053047552301	29	0.3001	0.440993375014352	Downstream signaling of activated FGFR2	440
217	14	3.716806676122	14	0.3002	0.440993375014352	Glycosaminoglycan biosynthesis - keratan sulfate	665
335	44	8.10380830820976	44	0.3005	0.440993375014352	Proteasome	1267
892	35	6.73467052685765	35	0.3005	0.440993375014352	EGFR interacts with phospholipase C-gamma	462
1436	13	3.51337582585129	13	0.3012	0.441374769828833	RHO GTPases activate IQGAPs	1406
1195	49	8.80380386956555	49	0.3016	0.441374769828833	Metabolism of fat-soluble vitamins	937
814	14	3.53961607852086	14	0.3027	0.441951302515252	DCC mediated attractive signaling	366
430	14	3.59839559232732	14	0.3045	0.441951302515252	Atypical NF-kappaB pathway	149
55	19	4.57937306065225	19	0.3046	0.441951302515252	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1630
1369	12	3.37826109118182	12	0.3047	0.441951302515252	Phospholipase C-mediated cascade; FGFR3	1181
385	22	4.87096063380402	22	0.3052	0.441951302515252	Terpenoid backbone biosynthesis	1686
263	118	15.9682292499627	118	0.3053	0.441951302515252	Lysosome	899
1449	62	12.1287718817644	62	0.3053	0.441951302515252	RNA Polymerase I Promoter Opening	1429
438	28	5.74807029241411	28	0.3056	0.441951302515252	CD40/CD40L signaling	233
1214	15	3.79004406273056	15	0.3061	0.441951302515252	Mismatch Repair	964
77	317	35.630914718527	298	0.3062	0.441951302515252	Human Immunodeficiency Virus type 1 (ssRNART)	753
1502	28	5.73811838402784	28	0.3081	0.442919560787785	Regulation of TNFR1 signaling	1364
87	19	4.77002384779942	17	0.3083	0.442919560787785	SARS Coronavirus (ssRNA)	1473
645	18	4.54532003937027	18	0.309	0.442919560787785	Acyl chain remodelling of PG	50
99	66	10.4674065343187	66	0.3092	0.442919560787785	Adherens junction	60
521	14	3.58672987343185	14	0.3093	0.442919560787785	RXR and RAR heterodimerization with other nuclear receptor	1461
437	22	4.70155650099304	22	0.3094	0.442919560787785	C-MYC pathway	202
238	35	6.61233213730411	35	0.3108	0.443968064430382	Homologous recombination	739
551	21	4.5879851743806	21	0.3112	0.443968064430382	Signaling events mediated by the Hedgehog family	1572
1665	97	14.0011058936119	97	0.3114	0.443968064430382	Stimuli-sensing channels	1610
637	41	7.04101759017554	41	0.3135	0.444581520061402	Activation of gene expression by SREBF (SREBP)	30
766	180	22.0306604818918	180	0.3136	0.444581520061402	Cilium Assembly	284
571	79	11.9123792144482	79	0.3138	0.444581520061402	Validated targets of C-MYC transcriptional activation	1825
1047	10	2.86281427074105	10	0.3143	0.444581520061402	HDR through MMEJ (alt-NHEJ)	700
1732	78	12.859641915809	78	0.3144	0.444581520061402	Telomere Maintenance	1683
1866	56	9.20366119382112	56	0.3146	0.444581520061402	tRNA processing in the nucleus	1800
1766	37	6.89587891922859	37	0.3154	0.444581520061402	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1760
401	32	6.47802838832731	32	0.316	0.444581520061402	Tyrosine metabolism	1810
1017	82	11.7387664240004	82	0.3166	0.444581520061402	Global Genome Nucleotide Excision Repair (GG-NER)	631
1611	19	4.0891944183205	19	0.317	0.444581520061402	Signaling by FGFR2 IIIa TM	1522
1857	15	3.55610372459079	15	0.3173	0.444581520061402	p75NTR signals via NF-kB	1140
1419	12	3.05566014732536	12	0.3176	0.444581520061402	Pyrimidine catabolism	1287
1165	12	3.19533598407715	12	0.3178	0.444581520061402	Lysine catabolism	896
1316	10	2.99142835827373	10	0.3182	0.444581520061402	Organic cation transport	1114
1335	88	12.371216616912	88	0.3184	0.444581520061402	PI3K/AKT Signaling in Cancer	1202
148	61	9.52185851691255	61	0.3186	0.444581520061402	Central carbon metabolism in cancer	257
889	41	7.18487136321705	41	0.3192	0.444828032316079	E3 ubiquitin ligases ubiquitinate target proteins	454
546	50	8.43483035770335	50	0.3223	0.445896437155601	Signaling events mediated by PTP1B	1569
543	38	6.80256776906469	38	0.3229	0.445896437155601	Signaling events mediated by HDAC Class III	1566
1207	24	4.79338201054429	24	0.3231	0.445896437155601	Metal ion SLC transporters	950
781	21	4.70376006919558	21	0.3234	0.445896437155601	Common Pathway of Fibrin Clot Formation	312
321	15	3.65647815049253	15	0.3248	0.445896437155601	Phenylalanine metabolism	1178
520	52	8.48299053330092	52	0.3249	0.445896437155601	RAC1 signaling pathway	1300
825	31	5.80125141663381	31	0.3249	0.445896437155601	DNA strand elongation	428
192	86	11.8438209180437	86	0.325	0.445896437155601	Fc gamma R-mediated phagocytosis	535
885	40	6.86034439922858	40	0.325	0.445896437155601	Dual Incision in GG-NER	447
894	47	7.75241697696352	47	0.3253	0.445896437155601	EPH-ephrin mediated repulsion of cells	480
203	63	9.30673477451425	63	0.3257	0.445896437155601	Glioma	630
985	63	9.61036406058423	63	0.3265	0.445896437155601	G1/S DNA Damage Checkpoints*	600
743	192	22.4117764774844	192	0.3271	0.445896437155601	Cell Cycle Checkpoints	244
266	19	4.07098422763349	19	0.3274	0.445896437155601	Mannose type O-glycan biosynthesis	906
839	10	2.70210201178863	10	0.3277	0.445896437155601	Defective EXT1 causes exostoses 1, TRPS2 and CHDS*	379
1585	27	5.11884693153097	27	0.3281	0.445896437155601	Sema4D in semaphorin signaling	1483
1697	43	7.24119460161628	43	0.3291	0.445896437155601	TBC/RABGAPs	1676
578	48	7.71907480903651	48	0.3292	0.445896437155601	amb2 Integrin signaling	84
937	12	2.99981765343797	12	0.3292	0.445896437155601	FGFR2c ligand binding and activation	552
700	76	11.1431512730438	76	0.3296	0.445896437155601	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	189
1270	15	3.56151553894112	15	0.33	0.445896437155601	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	1035
762	251	28.7059517955191	251	0.3301	0.445896437155601	Chromatin modifying enzymes*	279
1581	11	2.76909440426793	11	0.3301	0.445896437155601	SeMet incorporation into proteins	1486
1612	42	6.91521150835669	42	0.3308	0.445896437155601	Signaling by FGFR2 in disease	1523
35	29	5.54708650530426	29	0.331	0.445896437155601	phospholipases	1185
847	55	8.79085230716512	55	0.331	0.445896437155601	Degradation of DVL	388
471	41	7.13916214221907	41	0.332	0.446502813036945	FOXA1 transcription factor network	576
1381	87	11.7623049489997	87	0.3323	0.446502813036945	Platelet homeostasis	1219
1055	18	3.9290168553925	18	0.3336	0.447396860416917	HS-GAG degradation	746
1856	12	2.83658928107028	12	0.3365	0.447396860416917	p75NTR recruits signalling complexes	1139
154	111	13.8073514657794	111	0.3369	0.447396860416917	Cholinergic synapse	275
406	117	14.8404357572125	117	0.337	0.447396860416917	Vascular smooth muscle contraction	1831
901	15	3.33633114488159	15	0.3371	0.447396860416917	ERBB2 Regulates Cell Motility	501
907	14	3.37425020278265	14	0.3374	0.447396860416917	Eicosanoid ligand-binding receptors	464
746	79	11.1098015298509	79	0.3379	0.447396860416917	Cell junction organization	247
567	32	5.61260884360034	32	0.3393	0.447396860416917	Trk receptor signaling mediated by PI3K and PLC-gamma	1795
810	33	5.4779477336052	33	0.3396	0.447396860416917	DAG and IP3 signaling	362
347	30	5.29639295585411	30	0.3397	0.447396860416917	RNA polymerase	1425
1745	18	3.69234370849564	18	0.3412	0.447396860416917	Tie2 Signaling	1710
120	43	6.96728416400682	43	0.3417	0.447396860416917	Arginine and proline metabolism	131
686	92	13.5111880483173	92	0.342	0.447396860416917	B-WICH complex positively regulates rRNA expression	164
748	120	14.9766020416027	120	0.342	0.447396860416917	Cell-Cell communication	249
732	27	4.70699563801907	27	0.3422	0.447396860416917	Calmodulin induced events*	211
179	48	7.18762496275718	48	0.3425	0.447396860416917	Endometrial cancer	472
1712	42	6.88933395855049	42	0.344	0.447396860416917	TP53 Regulates Transcription of Cell Death Genes	1737
487	60	8.92748011086316	60	0.3444	0.447396860416917	IL12-mediated signaling events	770
647	22	4.44881291326637	22	0.3444	0.447396860416917	Acyl chain remodelling of PS	52
1249	12	2.90121187210007	12	0.3446	0.447396860416917	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1053
1153	19	3.88211594527321	19	0.3448	0.447396860416917	Lagging Strand Synthesis	868
368	80	10.2489686492863	80	0.3452	0.447396860416917	Small cell lung cancer	1588
413	25	5.05279262543821	25	0.3462	0.447396860416917	alpha-Linolenic acid metabolism	81
683	61	8.74802423942672	61	0.3464	0.447396860416917	Autodegradation of Cdh1 by Cdh1:APC/C	154
1565	67	10.8833274176231	67	0.3466	0.447396860416917	SIRT1 negatively regulates rRNA Expression	1583
1321	62	8.95467084576907	62	0.3472	0.447396860416917	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1125
1614	10	2.48413870892031	10	0.3472	0.447396860416917	Signaling by FGFR3 fusions in cancer	1525
1079	20	3.97241962678186	20	0.3473	0.447396860416917	IL-6-type cytokine receptor ligand interactions	767
821	299	29.9740194323639	299	0.3483	0.447396860416917	DNA Repair	424
1351	50	8.31282646324818	50	0.3488	0.447396860416917	Packaging Of Telomere Ends	1141
1706	13	2.95361434228881	13	0.3488	0.447396860416917	TNFR1-induced proapoptotic signaling	1718
38	27	4.81503386415613	27	0.3489	0.447396860416917	purine nucleotides de novo biosynthesis	1283
377	63	8.65923611233625	63	0.3494	0.447396860416917	Synaptic vesicle cycle	1636
1837	12	2.70716910541001	12	0.3496	0.447396860416917	eNOS activation	477
90	51	7.74034364586308	47	0.3498	0.447396860416917	Vaccinia Virus (dsDNA)	1824
482	11	2.4674065343742	11	0.3498	0.447396860416917	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	761
478	64	8.73366078255699	64	0.3503	0.447396860416917	HIF-1-alpha transcription factor network	725
1833	16	3.34525581175765	16	0.3505	0.447396860416917	activated TAK1 mediates p38 MAPK activation	19
1488	51	7.64340667460924	51	0.3508	0.447396860416917	Regulation of Apoptosis	1327
658	27	4.97056078652086	27	0.3514	0.447396860416917	Amino acid transport across the plasma membrane	89
1117	52	7.83181621442578	52	0.3515	0.447396860416917	Interactions of neurexins and neuroligins at synapses	818
1439	91	13.0982975034286	91	0.3515	0.447396860416917	RHO GTPases activate PKNs	1410
724	15	3.1940692814154	15	0.3516	0.447396860416917	CRMPs in Sema3A signaling	338
857	34	5.76324684400128	34	0.3517	0.447396860416917	Detoxification of Reactive Oxygen Species	399
6	23	4.17429329409556	23	0.3552	0.450770500698693	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	359
1046	67	9.03360044616557	67	0.3558	0.450770500698693	HDR through Homologous Recombination (HRR)	699
304	49	7.1603270207566	49	0.3569	0.450770500698693	Ovarian steroidogenesis	1121
1555	58	8.10202584864482	58	0.3579	0.450770500698693	SCF(Skp2)-mediated degradation of p27/p21	1477
1269	20	3.92028739200126	20	0.3582	0.450770500698693	Negative regulation of MET activity	1034
1334	10	2.31667551326137	10	0.3582	0.450770500698693	PI3K events in ERBB4 signaling	1199
1824	25	4.5745272747449	25	0.3582	0.450770500698693	WNT ligand biogenesis and trafficking	1858
1131	43	6.55621076685297	43	0.3584	0.450770500698693	Intra-Golgi traffic	836
1746	28	4.80159377732897	28	0.3586	0.450770500698693	Tight junction interactions	1712
158	28	4.71617425176284	28	0.3588	0.450770500698693	Citrate cycle (TCA cycle)	290
1822	50	7.28512619608089	50	0.3594	0.450770500698693	Vpu mediated degradation of CD4	1856
564	41	6.28057192547497	41	0.3595	0.450770500698693	TNF receptor signaling pathway	1713
70	95	11.2666199042878	91	0.3605	0.450839070034588	Hepatitis B virus (dsDNART)	715
297	25	4.4022106008666	25	0.3609	0.450839070034588	O-glycan biosynthesis, mucin type core	1099
1215	14	2.84650100735118	14	0.361	0.450839070034588	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	965
1254	44	6.43514581510119	44	0.3613	0.450839070034588	NOTCH1 Intracellular Domain Regulates Transcription	1081
28	24	4.339118697825	24	0.3617	0.450839070034588	heparan sulfate biosynthesis	710
935	32	5.09581503764953	32	0.3625	0.451300874864858	FGFR2 mutant receptor activation	550
1453	145	17.0589271202648	145	0.363	0.451388538287195	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1433
753	72	9.46635708277239	72	0.3647	0.452966424160275	Cellular response to hypoxia*	253
228	94	10.8575412843622	94	0.3657	0.453385021650669	HIF-1 signaling pathway	724
1541	40	6.07452422540944	40	0.3659	0.453385021650669	Retinoid metabolism and transport	1393
573	32	4.89095986225223	32	0.3675	0.453969665273967	Validated transcriptional targets of AP1 family members Fra1 and Fra2	1827
923	28	4.54681545256086	28	0.3678	0.453969665273967	Extension of Telomeres	515
1498	16	3.05218583602229	16	0.368	0.453969665273967	Regulation of KIT signaling	1345
1815	50	7.07696762612209	50	0.3681	0.453969665273967	Vif-mediated degradation of APOBEC3G	1842
1415	10	2.09362094832616	10	0.3698	0.454548844938169	Purine catabolism	1279
241	90	11.20998309637	90	0.3701	0.454548844938169	IL-17 signaling pathway	766
1346	35	5.09008612556915	35	0.3701	0.454548844938169	PLC-gamma1 signalling	1223
187	12	2.44632061617898	12	0.3703	0.454548844938169	Fatty acid biosynthesis	525
1527	13	2.74576275046829	13	0.371	0.454760045574741	Removal of the Flap Intermediate	1374
976	48	6.38296528800003	48	0.3714	0.454760045574741	G alpha (z) signalling events	591
789	20	3.61739574253651	20	0.3728	0.454760045574741	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants*	321
1735	12	2.47297994218078	12	0.3732	0.454760045574741	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1687
1031	14	2.7403319020771	14	0.3737	0.454760045574741	Glycogen synthesis	656
791	54	7.36010067606776	54	0.3739	0.454760045574741	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants*	323
1806	31	4.77247894869239	31	0.3744	0.454760045574741	Uptake and actions of bacterial toxins	1821
938	12	2.50265115760128	12	0.3746	0.454760045574741	FGFR3 ligand binding and activation*	553
56	12	2.4706641750568	12	0.3748	0.454760045574741	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1631
111	91	10.8094977204337	91	0.3748	0.454760045574741	Amoebiasis	92
919	88	10.246688506995	90	0.3776	0.45639483347923	Eukaryotic Translation Elongation*	511
1107	25	3.97913644572148	25	0.3786	0.45639483347923	Insulin processing	805
1776	39	5.5491903090957	39	0.3788	0.45639483347923	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1771
80	183	18.7204425804315	167	0.3794	0.45639483347923	Human papillomavirus (dsDNA)	754
225	90	10.277099873537	90	0.3794	0.45639483347923	GnRH signaling pathway	677
897	21	3.58678801154734	21	0.3802	0.45639483347923	ER Quality Control Compartment (ERQC)	494
1274	19	3.1421678356355	19	0.381	0.45639483347923	Nephrin interactions	1039
952	14	2.88558606436663	14	0.3816	0.45639483347923	Fatty acids	530
1713	61	7.43124189402936	61	0.3818	0.45639483347923	TP53 Regulates Transcription of DNA Repair Genes	1739
1522	49	6.58046104712117	49	0.3819	0.45639483347923	Regulation of ornithine decarboxylase (ODC)	1352
656	17	3.04286064892774	17	0.383	0.45639483347923	Amine-derived hormones	87
972	83	9.45486070194652	83	0.383	0.45639483347923	G alpha (12/13) signalling events	587
36	27	3.91568169975495	27	0.384	0.45639483347923	protein ubiquitylation	1274
818	77	9.82698477276391	77	0.384	0.45639483347923	DNA Damage/Telomere Stress Induced Senescence	420
73	112	12.7449565552271	105	0.3841	0.45639483347923	Herpes Simplex Virus (dsDNA)	720
1467	28	4.35344011152748	28	0.3841	0.45639483347923	RNA Polymerase III Transcription Initiation From Type 1 Promoter*	1448
534	25	3.97440833910686	25	0.3843	0.45639483347923	Retinoic acid receptors-mediated signaling	1392
728	29	4.22666790493664	29	0.3843	0.45639483347923	Ca-dependent events	205
933	27	3.88224627537713	27	0.3844	0.45639483347923	FGFR2 alternative splicing	548
1283	15	2.77146168749534	15	0.3861	0.457206813336823	Nicotinamide salvaging	1056
1160	111	12.6438939384653	111	0.3863	0.457206813336823	Lipid digestion, mobilization, and transport	883
1599	22	3.35932975908076	22	0.3869	0.457206813336823	Signaling by BMP	1509
114	28	4.23662931588729	28	0.3871	0.457206813336823	Antifolate resistance	100
1201	79	9.28065613527558	79	0.3881	0.457206813336823	Metabolism of polyamines	943
596	65	7.82578118521061	65	0.3884	0.457206813336823	APC/C:Cdc20 mediated degradation of Securin	114
150	99	10.689983748857	99	0.3887	0.457206813336823	Chagas disease (American trypanosomiasis)	263
184	41	5.44331364981427	41	0.3889	0.457206813336823	Ether lipid metabolism	510
411	23	3.77400186290752	23	0.389	0.457206813336823	Vitamin digestion and absorption	1851
1167	290	27.3758431176514	290	0.39	0.457869993359327	M Phase	901
280	29	4.32072117609339	29	0.3913	0.458883507667545	Mucin type O-glycan biosynthesis	1002
1232	136	14.9286141631617	136	0.3926	0.45973366098406	Mitotic Prophase	983
456	33	4.61779707145811	33	0.3929	0.45973366098406	E-cadherin signaling in the nascent adherens junction	450
1210	15	2.59542830131387	15	0.3935	0.459762269241179	Methylation	955
1305	35	4.93349729162293	35	0.3954	0.459762269241179	O-glycosylation of TSR domain-containing proteins*	1100
221	14	2.39491127040702	14	0.3957	0.459762269241179	Glycosphingolipid biosynthesis - globo and isoglobo series	670
1431	109	11.0863641601502	109	0.396	0.459762269241179	RHO GTPases Activate Formins	1405
1718	20	3.04137566565065	20	0.396	0.459762269241179	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1734
925	53	6.72468063147347	53	0.3965	0.459762269241179	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	532
629	64	7.58704719245983	64	0.3966	0.459762269241179	Activation of NF-kappaB in B cells	35
1814	619	51.7860356446226	619	0.3967	0.459762269241179	Vesicle-mediated transport	1840
802	38	5.08090943973446	38	0.397	0.459762269241179	Cyclin D associated events in G1*	346
1184	62	7.36462097530902	62	0.3973	0.459762269241179	Macroautophagy	903
443	27	3.83676398950987	27	0.3985	0.460368345689957	Calcium signaling in the CD4+ TCR pathway	209
1202	16	2.68107950457624	16	0.3987	0.460368345689957	Metabolism of porphyrins	944
500	41	5.28979446327349	41	0.3992	0.460395693221481	LKB1 signaling events	887
931	31	4.22678666599216	31	0.3996	0.460395693221481	FGFR1 mutant receptor activation	546
258	64	7.32590261649076	64	0.4001	0.460437229648714	Long-term potentiation	889
511	46	5.66100096856399	46	0.4007	0.460437229648714	Notch-mediated HES/HEY network	1080
1715	20	3.11984509696457	20	0.4019	0.460437229648714	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1740
720	78	8.77614795797743	78	0.4025	0.460437229648714	COPI-mediated anterograde transport	330
1193	329	28.4016710448446	329	0.4035	0.460437229648714	Metabolism of amino acids and derivatives	934
454	48	5.77410712465861	48	0.4039	0.460437229648714	Downstream signaling in naive CD8+ T cells	438
1148	41	5.15596771503071	41	0.404	0.460437229648714	Kinesins	864
1457	142	13.8460509781714	142	0.4041	0.460437229648714	RNA Polymerase II Transcription	1438
1392	99	10.072831109603	99	0.405	0.460437229648714	Potassium Channels	1236
1140	42	5.26796632259514	42	0.4061	0.460437229648714	Iron uptake and transport	849
1819	16	2.57637424652139	16	0.4062	0.460437229648714	Vitamin B5 (pantothenate) metabolism	1850
190	43	5.28742268112102	43	0.4066	0.460437229648714	Fatty acid metabolism	528
1317	15	2.62254867051931	15	0.4066	0.460437229648714	Organic cation/anion/zwitterion transport	1115
1440	81	9.32335658200908	81	0.407	0.460437229648714	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1418
278	60	6.85402597755541	60	0.4075	0.460437229648714	Mitophagy - animal	977
159	21	3.03241631758163	21	0.4076	0.460437229648714	Citrate cycle (TCA cycle, Krebs cycle)	289
479	30	4.04155570577557	30	0.4082	0.460437229648714	HIF-2-alpha transcription factor network	726
1095	147	13.8840269761248	147	0.4082	0.460437229648714	Influenza Infection	789
1114	28	4.08350955675844	28	0.4083	0.460437229648714	Interaction between L1 and Ankyrins	816
446	48	5.54749464482113	48	0.4084	0.460437229648714	Caspase cascade in apoptosis	227
829	53	6.02964044305303	53	0.4096	0.461251287715382	Deadenylation-dependent mRNA decay	369
934	19	2.85787087835422	19	0.41	0.461251287715382	FGFR2 ligand binding and activation	549
962	16	2.46477806472847	16	0.4111	0.461994150751865	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	568
1781	79	8.40393811515268	79	0.4127	0.463296726118118	Transport of Mature Transcript to Cytoplasm	1781
1068	41	5.02174273811088	41	0.4168	0.467400024198314	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	731
1438	21	2.86947547421589	21	0.4192	0.468934748656415	RHO GTPases activate PAKs	1409
1805	12	1.9191354713606	12	0.4195	0.468934748656415	Unwinding of DNA	1820
1770	147	13.3406575879756	147	0.4197	0.468934748656415	Translation	1765
510	58	6.23945301674507	58	0.4203	0.468934748656415	Notch signaling pathway (PID)	1078
185	47	5.31798532330789	47	0.4204	0.468934748656415	Fanconi anemia pathway	519
355	20	2.76819478134095	20	0.421	0.469106028626119	Renin-angiotensin system	1378
470	47	5.29277835838192	47	0.4223	0.469558691860267	FGF signaling pathway	544
1865	100	9.84010188934613	100	0.4223	0.469558691860267	tRNA processing	1799
392	162	14.8234911230034	162	0.4232	0.470061988845753	Tight junction	1711
255	107	10.2051739569823	107	0.424	0.47012612808741	Leukocyte transendothelial migration	877
595	23	3.10260052041034	23	0.4244	0.47012612808741	APC/C:Cdc20 mediated degradation of Cyclin B	112
808	19	2.68550965808161	19	0.4246	0.47012612808741	Cytosolic sulfonation of small molecules	356
831	57	6.11456539180816	57	0.4253	0.470405497482513	Dectin-1 mediated noncanonical NF-kB signaling*	371
1058	97	9.4769937805359	97	0.4264	0.471126236419783	Hedgehog 'off' state	702
518	25	3.01387946214463	25	0.4291	0.473279387333011	Plasma membrane estrogen receptor signaling	1212
42	14	2.07756600657853	14	0.4295	0.473279387333011	pyrimidine deoxyribonucleotides de novo biosynthesis	1290
1811	22	2.89386070638011	22	0.4297	0.473279387333011	VLDL interactions	1852
1260	18	2.36588587749668	18	0.4309	0.47355249760633	Na+/Cl- dependent neurotransmitter transporters	1019
1188	76	7.80276229511423	76	0.4312	0.47355249760633	Meiotic synapsis	921
695	10	1.49356634981081	10	0.4313	0.47355249760633	Beta-oxidation of pristanoyl-CoA	180
598	70	7.07000982993595	70	0.4319	0.473716275542114	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	115
616	16	2.11812371570152	16	0.4328	0.474208414608421	Activated point mutants of FGFR2	18
153	93	8.70948075202603	93	0.4339	0.474918435246148	Choline metabolism in cancer	274
1234	12	1.76140781178	12	0.4346	0.475189620072567	Mitotic Telophase/Cytokinesis	985
1618	11	1.58831490540345	11	0.4359	0.475506534766883	Signaling by FGFR4 in disease	1529
1245	35	3.89649248052364	35	0.4364	0.475506534766883	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1018
549	63	6.22317207587575	63	0.4365	0.475506534766883	Signaling events mediated by VEGFR1 and VEGFR2	1573
1229	176	15.2257815864332	176	0.4367	0.475506534766883	Mitotic G2-G2/M phases*	980
790	15	2.09691018611495	15	0.4391	0.477605122031599	Constitutive Signaling by NOTCH1 HD Domain Mutants*	322
803	69	6.91305376671302	71	0.4396	0.477605122031599	Cyclin E associated events during G1/S transition*	347
968	71	7.23989853332189	71	0.4405	0.477605122031599	Formation of the cornified envelope	571
1668	27	3.16456001504999	27	0.4406	0.477605122031599	Surfactant metabolism	1634
995	19	2.29880131437284	19	0.4409	0.477605122031599	GABA synthesis, release, reuptake and degradation	610
233	127	11.424679456657	127	0.4415	0.477762533605292	Hepatitis C	716
848	58	5.82984044666238	58	0.4421	0.477919621286857	Degradation of GLI1 by the proteasome	389
320	145	12.5734394178793	145	0.4437	0.478054942611232	Phagosome	1171
1583	87	7.6406127102995	87	0.4437	0.478054942611232	Selenocysteine synthesis	1480
374	33	3.64430948717776	33	0.444	0.478054942611232	Starch and sucrose metabolism	1606
798	12	1.60520536344593	12	0.4445	0.478054942611232	Creation of C4 and C2 activators	335
1769	29	3.11665812821156	29	0.4445	0.478054942611232	Transferrin endocytosis and recycling	1764
1556	53	5.26416634984089	53	0.4466	0.479379220977773	SCF-beta-TrCP mediated degradation of Emi1	1476
1150	91	8.42374410925541	91	0.4469	0.479379220977773	L1CAM interactions	867
1596	12	1.61585822009073	12	0.4471	0.479379220977773	Signal regulatory protein (SIRP) family interactions	1503
143	42	4.26543922340352	42	0.4483	0.480175881833223	Carbohydrate digestion and absorption	218
175	78	7.03748367899928	78	0.4493	0.480359437507968	EGFR tyrosine kinase inhibitor resistance	463
13	12	1.65183004205842	12	0.4494	0.480359437507968	bile acid biosynthesis, neutral pathway	184
1823	20	2.33605226835929	20	0.45	0.480359437507968	VxPx cargo-targeting to cilium	1857
1302	109	9.60469684661561	109	0.4503	0.480359437507968	Nucleotide Excision Repair	1096
761	46	4.60310801732655	46	0.4517	0.481364198835922	Chondroitin sulfate/dermatan sulfate metabolism	278
63	78	7.26867939200263	73	0.4526	0.481834627854457	Adenovirus (dsDNA)	57
774	128	10.7639640095742	128	0.4539	0.482729510633473	Clathrin-mediated endocytosis	300
1368	17	1.91978364806986	17	0.455	0.482732616568854	Phospholipase C-mediated cascade; FGFR2	1180
1230	166	13.4672347320317	166	0.4552	0.482732616568854	Mitotic Metaphase and Anaphase*	981
1014	135	11.4462545483322	135	0.4553	0.482732616568854	Gene Silencing by RNA	626
1543	45	4.24538668294179	45	0.4559	0.482732616568854	Retrograde transport at the Trans-Golgi-Network	1398
363	82	7.22820616344911	82	0.4562	0.482732616568854	Salmonella infection	1472
710	21	2.29211137944656	21	0.4572	0.483304065579829	CD28 dependent PI3K/Akt signaling	231
1390	954	69.9485841881503	954	0.4578	0.483451952709987	Post-translational protein modification	1234
1645	284	22.06982905468	287	0.4613	0.486658964069891	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)*	1559
918	11	1.23048710198336	11	0.4624	0.486947125985758	Ethanol oxidation	509
1221	21	2.18181305417015	21	0.4625	0.486947125985758	Mitochondrial tRNA aminoacylation	975
1451	47	4.29178637138085	47	0.4642	0.487346257016684	RNA Polymerase I Transcription Initiation	1431
222	26	2.54777368769559	26	0.4644	0.487346257016684	Glycosphingolipid biosynthesis - lacto and neolacto series	671
1261	10	1.10390815569844	10	0.465	0.487346257016684	Nef Mediated CD4 Down-regulation	1025
1659	35	3.27969505422824	35	0.4654	0.487346257016684	Smooth Muscle Contraction	1589
462	32	3.0319936950012	32	0.4655	0.487346257016684	EPO signaling pathway	491
1711	48	4.25046561713134	48	0.4657	0.487346257016684	TP53 Regulates Transcription of Cell Cycle Genes	1736
1609	38	3.45060100379493	38	0.4666	0.487346257016684	Signaling by FGFR1 in disease	1520
1642	30	2.99765554210255	30	0.4668	0.487346257016684	Signaling by Robo receptor	1555
141	10	1.18521857104867	10	0.4684	0.487346257016684	C5 isoprenoid biosynthesis, mevalonate pathway*	204
849	58	5.04626467101515	59	0.4687	0.487346257016684	Degradation of GLI2 by the proteasome*	390
494	42	3.83496348955995	42	0.4694	0.487346257016684	IL6-mediated signaling events	777
1685	34	3.23848448217838	34	0.4699	0.487346257016684	Synthesis of bile acids and bile salts	1646
1213	17	1.83440239647307	17	0.47	0.487346257016684	Miscellaneous transport and binding events	962
716	13	1.37096273934711	13	0.4702	0.487346257016684	CLEC7A (Dectin-1) induces NFAT activation	302
1514	12	1.35025683039703	12	0.4703	0.487346257016684	Regulation of gene expression by Hypoxia-inducible Factor	1335
1716	13	1.33162964307734	13	0.4703	0.487346257016684	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1741
916	146	11.3571606820033	146	0.471	0.487590770116604	Epigenetic regulation of gene expression	489
308	70	5.72121768763988	70	0.4724	0.488111391772841	PPAR signaling pathway	1238
1231	101	7.83326049366583	101	0.4733	0.488111391772841	Mitotic Prometaphase	982
126	119	9.05529877188811	119	0.4739	0.488111391772841	Autophagy - animal	157
485	33	2.86729739345947	33	0.4745	0.488111391772841	IL1-mediated signaling events	768
50	63	5.25040138807108	63	0.4746	0.488111391772841	superpathway of inositol phosphate compounds	1625
334	83	6.48844121659042	83	0.4755	0.488111391772841	Prostate cancer	1266
1780	201	14.9019057829898	201	0.4756	0.488111391772841	Transmission across Chemical Synapses	1775
459	31	2.69492425717177	31	0.4758	0.488111391772841	EPHA forward signaling	482
23	16	1.59653648413452	16	0.4763	0.488111391772841	glutathione-mediated detoxification	650
689	37	3.18742474680432	37	0.4768	0.488111391772841	Base Excision Repair*	170
472	44	3.61722131948866	44	0.4769	0.488111391772841	FOXA2 and FOXA3 transcription factor networks	577
1516	15	1.4575010594409	15	0.4774	0.488111391772841	Regulation of innate immune responses to cytosolic DNA	1342
1189	581	41.439407595134	581	0.4779	0.488111391772841	Membrane Trafficking	926
191	66	5.37456827872992	66	0.4787	0.488111391772841	Fc epsilon RI signaling pathway	534
442	44	3.53109588611829	44	0.4788	0.488111391772841	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	207
12	10	1.03027212657652	10	0.4792	0.488111391772841	adenosine deoxyribonucleotides de novo biosynthesis*	56
504	33	2.84790495093833	33	0.4794	0.488111391772841	N-cadherin signaling events	1012
1025	29	2.49256747200232	29	0.4799	0.488147466385587	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity*	644
1474	16	1.40009525750099	16	0.4807	0.488488331840516	Rap1 signalling	1305
300	113	8.37532805926674	113	0.4815	0.488828538618238	Oocyte meiosis	1109
965	35	2.8572849454104	35	0.4824	0.489269512654447	Formation of the Early Elongation Complex*	572
936	10	0.969556321288741	10	0.4844	0.490721826721621	FGFR2b ligand binding and activation	551
577	31	2.54731599181943	31	0.485	0.490721826721621	a6b1 and a6b4 Integrin signaling	6
41	14	1.33529363195719	14	0.4854	0.490721826721621	pyrimidine deoxyribonucleotides biosynthesis from CTP	1289
718	80	6.27152181606643	80	0.4857	0.490721826721621	COPI-dependent Golgi-to-ER retrograde traffic	328
389	29	2.45350440990737	29	0.4864	0.49095699024392	Thyroid cancer	1706
1607	62	4.50713879620675	62	0.4869	0.490990022371075	Signaling by FGFR in disease	1518
102	34	2.78091624290857	34	0.4881	0.491728194468681	African trypanosomiasis	69
655	39	3.04774740580787	39	0.4889	0.492042921974523	Amine ligand-binding receptors	86
1717	19	1.64930066149498	19	0.4894	0.492042921974523	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1742
1192	15	1.30448859469301	15	0.4904	0.492042921974523	Metabolism of Angiotensinogen to Angiotensins	935
1322	21	1.74409851822981	21	0.4908	0.492042921974523	PCNA-Dependent Long Patch Base Excision Repair	1154
1714	12	1.01219455251468	12	0.491	0.492042921974523	TP53 Regulates Transcription of Death Receptors and Ligands	1738
1476	10	0.927267791185148	10	0.4928	0.492042921974523	Reactions specific to the complex N-glycan synthesis pathway	1309
1829	28	2.0523875984566	28	0.4928	0.492042921974523	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1865
1773	17	1.43827782549359	17	0.4929	0.492042921974523	Translesion synthesis by POLI	1768
1676	22	1.84798509994931	22	0.4931	0.492042921974523	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1654
1731	23	1.97682678306507	23	0.4934	0.492042921974523	Telomere C-strand (Lagging Strand) Synthesis	1682
1353	13	1.11757648689621	13	0.4937	0.492042921974523	Passive transport by Aquaporins	1147
270	66	4.70094314294305	66	0.4944	0.492042921974523	Melanoma	923
1212	12	0.91418646907525	12	0.4945	0.492042921974523	Miscellaneous substrates	961
378	10	0.797448925363297	10	0.4964	0.493099084567158	Synthesis and degradation of ketone bodies	1642
788	16	1.37055320464403	16	0.4965	0.493099084567158	Constitutive Signaling by EGFRvIII*	320
93	42	3.04301174496094	42	0.4973	0.493427227402112	ABC transporters	9
419	147	10.0508042683167	147	0.4995	0.495142537992914	mTOR signaling pathway (KEGG)	997
949	33	2.33959536979292	33	0.5011	0.495623255734805	Fanconi Anemia Pathway	520
676	13	1.01740636972226	13	0.5012	0.495623255734805	Assembly Of The HIV Virion	138
1500	67	4.69346219056617	67	0.5014	0.495623255734805	Regulation of RAS by GAPs	1357
1651	18	1.33531172417828	18	0.5021	0.495777792556736	Signaling by cytosolic FGFR1 fusion mutants	1511
1350	27	2.0519828072504	27	0.5025	0.495777792556736	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1278
1089	10	0.769401658853337	10	0.504	0.495986838384686	Import of palmitoyl-CoA into the mitochondrial matrix	780
78	13	1.02892300520944	11	0.5042	0.495986838384686	Human T-lymphotropic virus (dsDNA)	755
875	13	0.97363018830087	13	0.5046	0.495986838384686	Downregulation of ERBB2:ERBB3 signaling	433
1505	14	0.967973673293395	14	0.5046	0.495986838384686	Regulation of TP53 Activity through Association with Co-factors	1367
1446	90	5.73384462063115	90	0.5068	0.497157345794298	RNA Polymerase I Chain Elongation	1426
1491	22	1.54366832490447	22	0.5079	0.497157345794298	Regulation of FZD by ubiquitination	1334
1342	17	1.1253823711681	17	0.5088	0.497157345794298	PKA-mediated phosphorylation of CREB	1209
96	52	3.55222183650393	52	0.5092	0.497157345794298	Acute myeloid leukemia	47
1807	13	0.903089431823329	13	0.5097	0.497157345794298	Uptake and function of anthrax toxins	1822
249	132	8.65134754793509	132	0.5099	0.497157345794298	Insulin signaling pathway	810
1772	18	1.22624053641783	18	0.5115	0.497157345794298	Translesion Synthesis by POLH	1767
262	11	0.798299387889904	11	0.5116	0.497157345794298	Lysine degradation, lysine => saccharopine => acetoacetyl-CoA	898
1622	307	19.988318258828	307	0.5129	0.497157345794298	Signaling by Insulin receptor	1534
359	144	8.83281695407716	144	0.5133	0.497157345794298	Ribosome	1415
865	23	1.42136330310675	23	0.5136	0.497157345794298	Diseases associated with glycosaminoglycan metabolism	409
1788	11	0.602083430622778	11	0.5143	0.497157345794298	Transport of organic anions	1782
14	11	0.718411960407765	11	0.5145	0.497157345794298	cholesterol biosynthesis I*	271
497	45	2.89924328597543	45	0.5145	0.497157345794298	Integrins in angiogenesis	815
1347	12	0.848754450554328	12	0.5146	0.497157345794298	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1237
2	27	1.75347731842142	27	0.5148	0.497157345794298	3-phosphoinositide biosynthesis	3
404	59	3.6324574821159	59	0.515	0.497157345794298	VEGF signaling pathway	1834
1629	69	4.49394675868047	69	0.515	0.497157345794298	Signaling by NOTCH1	1542
556	11	0.686998088619266	11	0.5154	0.497157345794298	Sumoylation by RanBP2 regulates transcriptional repression	1616
493	56	4.01305339031969	56	0.5155	0.497157345794298	IL4-mediated signaling events	776
1171	15	0.989982978894786	15	0.5158	0.497157345794298	MAP3K8 (TPL2)-dependent MAPK1/3 activation	909
160	14	1.01098450553891	14	0.5162	0.497157345794298	Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate	291
253	68	4.38024909873932	68	0.519	0.499396311790585	Leishmaniasis	874
1108	26	1.4453099711228	26	0.5198	0.499635901275588	Insulin receptor recycling	806
895	34	1.96006801181578	34	0.5202	0.499635901275588	EPHA-mediated growth cone collapse	483
1557	13	0.742296705343257	13	0.5211	0.500043245329336	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	1482
168	34	2.14127245171741	34	0.5231	0.501504433852719	DNA replication	425
1682	46	2.72956827624468	46	0.5255	0.50231115844336	Synthesis of PIPs at the plasma membrane	1660
1765	104	5.74686535961957	104	0.5256	0.50231115844336	Transcriptional regulation by small RNAs	1759
193	37	2.22542227897489	37	0.5261	0.50231115844336	Ferroptosis	542
1533	34	1.9565570228523	34	0.5264	0.50231115844336	Resolution of D-Loop Structures*	1383
1373	19	1.08984115729096	19	0.5266	0.50231115844336	Phosphorylation of the APC/C	1188
799	48	2.85527263101703	48	0.5281	0.50231115844336	Cross-presentation of soluble exogenous antigens (endosomes)	339
1464	18	1.0603896377039	18	0.5282	0.50231115844336	RNA Polymerase III Chain Elongation	1445
163	59	3.21213949248329	59	0.5286	0.50231115844336	Colorectal cancer	311
299	19	0.995375292846495	19	0.5289	0.50231115844336	One carbon pool by folate	1108
507	55	3.17682356134321	55	0.529	0.50231115844336	Neurotrophic factor-mediated Trk receptor signaling	1049
636	119	6.55682670297647	119	0.5292	0.50231115844336	Activation of anterior HOX genes in hindbrain development during early embryogenesis*	21
426	18	1.0411090666646	18	0.53	0.502616475400345	Arf1 pathway	127
617	74	4.23116741160317	74	0.5306	0.502731746171027	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins*	22
1627	20	1.02782474084658	20	0.5317	0.503320121378824	Signaling by NODAL	1540
1569	32	1.82515991483612	32	0.5335	0.504059575988229	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1587
714	29	1.63703943720227	29	0.5339	0.504059575988229	CDO in myogenesis*	238
1759	14	0.741336668478203	14	0.534	0.504059575988229	Trafficking of GluR2-containing AMPA receptors	1751
569	29	1.54163681153214	29	0.5344	0.504059575988229	VEGFR1 specific signals	1836
1589	155	8.91472047671838	155	0.5353	0.504455646000913	Separation of Sister Chromatids	1488
1360	28	1.4493074200419	28	0.5359	0.504568545744717	Peroxisomal lipid metabolism	1168
887	32	1.69962120336035	32	0.5368	0.504963450932171	E2F mediated regulation of DNA replication	451
1775	16	0.752155839551785	16	0.5374	0.505075694500288	Translesion synthesis by REV1	1770
1652	32	1.72726687594158	32	0.5379	0.505093836387901	Signaling by high-kinase activity BRAF mutants	1532
558	30	1.37706430559878	30	0.5395	0.506143935367524	Syndecan-2-mediated signaling events	1639
793	19	0.893078978801867	19	0.5401	0.50617821795464	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	325
605	70	3.42297002871905	70	0.5405	0.50617821795464	AURKA Activation by TPX2*	151
34	25	1.22936712441236	25	0.5412	0.506382446659431	mucin core 1 and core 2 O-glycosylation	1001
288	114	5.86869790111539	114	0.5449	0.509031421107341	Neurotrophin signaling pathway	1050
440	33	1.49770835811447	33	0.545	0.509031421107341	CXCR3-mediated signaling events	342
1226	19	0.784658509846019	19	0.5456	0.509060427399501	Mitophagy*	976
1341	17	0.560735062470205	17	0.546	0.509060427399501	PKA activation in glucagon signalling	1208
286	122	5.97943572779601	122	0.549	0.510312902257523	Natural killer cell mediated cytotoxicity	1021
1487	78	3.9668493139725	78	0.5494	0.510312902257523	Regulation of APC/C activators between G1/S and early anaphase	1326
425	46	2.17433797568996	46	0.5496	0.510312902257523	Angiopoietin receptor Tie2-mediated signaling	99
876	22	0.844522645045711	22	0.5503	0.510312902257523	Downregulation of SMAD2/3:SMAD4 transcriptional activity	434
1859	52	2.53829270559258	52	0.5503	0.510312902257523	rRNA modification in the nucleus and cytosol	1458
91	11	0.313691993583019	11	0.5505	0.510312902257523	Varicella Zoster Virus (dsDNA)	1830
1531	24	0.99515262941852	24	0.5508	0.510312902257523	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1382
833	16	0.486952021787072	16	0.5517	0.510312902257523	Defective B3GALT6 causes EDSP2 and SEMDJL1*	373
594	84	4.24616973288826	84	0.5518	0.510312902257523	APC/C-mediated degradation of cell cycle proteins*	111
523	29	1.1927220817021	29	0.5522	0.510312902257523	Reelin signaling pathway	1318
806	10	0.307644596723205	10	0.553	0.510431604998797	Cytosolic iron-sulfur cluster assembly	354
764	100	4.76753533350343	100	0.5533	0.510431604998797	Chromosome Maintenance	281
1836	18	0.614649720195745	18	0.5543	0.510905571076411	cGMP effects	261
584	23	0.878911979442244	23	0.5558	0.511682901142202	A tetrasaccharide linker sequence is required for GAG synthesis	5
1037	52	2.39841904153314	52	0.5569	0.511682901142202	Golgi Associated Vesicle Biogenesis	678
1179	11	0.274759250225134	11	0.5575	0.511682901142202	MET activates RAP1 and RAC1	928
755	77	3.32715063962396	77	0.5579	0.511682901142202	Centrosome maturation*	258
281	47	2.038922766111	47	0.5585	0.511682901142202	N-Glycan biosynthesis	1015
384	11	0.291372670924674	11	0.5585	0.511682901142202	Taurine and hypotaurine metabolism	1675
142	172	8.4311617817282	172	0.5594	0.511682901142202	Calcium signaling pathway	210
1810	28	1.09724896970774	28	0.5594	0.511682901142202	VEGFR2 mediated vascular permeability	1838
544	71	3.25137889098203	71	0.56	0.511682901142202	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	1567
447	22	0.659430388730401	22	0.5602	0.511682901142202	Cellular roles of Anthrax toxin	255
1209	11	-0.376783622994769	11	0.5605	0.511682901142202	Metallothioneins bind metals*	952
576	27	1.05641007613195	27	0.5611	0.511785999110036	Wnt signaling network	1859
397	35	1.20844103471784	35	0.5633	0.513347031594462	Tryptophan metabolism	1805
729	61	2.50436994463347	61	0.5648	0.514267986853234	Ca2+ pathway	206
868	79	3.22783509632976	79	0.5654	0.514368578864692	Diseases of glycosylation	412
1580	12	0.0785004657746553	12	0.5698	0.517566202929449	Scavenging of heme from plasma	1475
750	14	0.212303741033787	14	0.5699	0.517566202929449	Cell-extracellular matrix interactions	251
109	47	1.4828185086665	47	0.572	0.518667604178624	Amino sugar and nucleotide sugar metabolism	90
691	24	0.544539376402297	24	0.5721	0.518667604178624	Basigin interactions	172
1290	89	3.61736070474018	89	0.5745	0.519428808625199	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1073
532	26	0.631739070140537	26	0.5746	0.519428808625199	Regulation of p38-alpha and p38-beta	1353
509	17	0.176718737527485	17	0.5753	0.519428808625199	Nongenotropic Androgen signaling	1070
942	13	-0.0254819011371538	13	0.5757	0.519428808625199	FGFRL1 modulation of FGFR1 signaling	557
1280	135	5.91117148456213	135	0.5759	0.519428808625199	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell	1047
89	10	0.0396697408219648	9	0.576	0.519428808625199	Sindbis Virus (ssRNA)	1582
1340	16	0.168831037455699	16	0.5764	0.519428808625199	PKA activation	1207
1499	85	3.1226605737064	85	0.5776	0.519723398010864	Regulation of PLK1 Activity at G2/M Transition	1354
282	15	0.26912377905476	15	0.5781	0.519723398010864	N-glycan biosynthesis, complex type	1016
672	49	1.44418761306672	49	0.5783	0.519723398010864	Apoptotic execution phase	123
398	173	7.34427989824091	173	0.5791	0.519723398010864	Tuberculosis	1806
492	26	0.50103512702853	26	0.5792	0.519723398010864	IL27-mediated signaling events	775
864	56	1.806471793223	56	0.5799	0.519827345625458	Diseases associated with O-glycosylation of proteins	410
1554	19	0.286084840688352	19	0.5804	0.519827345625458	SALM protein interactions at the synapses	1471
593	25	0.490176852092045	25	0.5808	0.519827345625458	APC-Cdc20 mediated degradation of Nek2A	109
1003	106	4.21546070253909	107	0.5818	0.519967527587989	GTP hydrolysis and joining of the 60S ribosomal subunit*	689
452	54	1.71435551085814	54	0.583	0.519967527587989	Coregulation of Androgen receptor activity	332
964	96	3.51365222743753	96	0.5835	0.519967527587989	Formation of a pool of free 40S subunits	562
431	31	0.596041921832405	31	0.5846	0.519967527587989	Aurora A signaling	152
1159	10	-0.119581160470026	10	0.5847	0.519967527587989	Ligand-independent caspase activation via DCC	881
696	10	0.00524753171734625	10	0.5848	0.519967527587989	Bicarbonate transporters	181
113	50	1.1907405831584	50	0.5849	0.519967527587989	Amyotrophic lateral sclerosis (ALS)	96
826	11	-0.0885992284026406	11	0.5855	0.519967527587989	DSCAM interactions	446
1736	12	0.0220472307374249	12	0.5856	0.519967527587989	The NLRP3 inflammasome	1697
794	43	1.08408256593418	43	0.586	0.519967527587989	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	326
517	22	0.362005662637155	22	0.5864	0.519967527587989	Paxillin-independent events mediated by a4b1 and a4b7	1153
758	12	0.00975585932099575	12	0.5871	0.520149280982463	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	269
858	273	12.2016341918495	273	0.5891	0.521169949574344	Deubiquitination	400
475	46	1.053937434329	46	0.5904	0.521169949574344	FoxO family signaling	579
1744	10	-0.0640974483313771	10	0.5905	0.521169949574344	Thyroxine biosynthesis	1709
1271	10	-0.156267757710444	10	0.5917	0.521169949574344	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	1028
613	30	0.572574023584134	30	0.5919	0.521169949574344	Activated NOTCH1 Transmits Signal to the Nucleus	16
733	26	0.504023416638923	26	0.592	0.521169949574344	Calnexin/calreticulin cycle	212
986	113	4.34252866110686	113	0.5925	0.521169949574344	G1/S Transition	601
82	11	-0.169497067115168	10	0.5935	0.521169949574344	JC Virus (dsDNA)	855
350	217	9.10712021442526	217	0.5938	0.521169949574344	Ras signaling pathway	1308
703	25	0.197671101527171	25	0.5942	0.521169949574344	Budding and maturation of HIV virion	197
1004	33	0.377048294391518	33	0.5942	0.521169949574344	Gamma carboxylation, hypusine formation and arylsulfatase activation	613
800	22	0.175176438277046	22	0.5945	0.521169949574344	Cyclin A/B1 associated events during G2/M transition	345
207	110	3.39768208219496	110	0.5947	0.521169949574344	Glutamatergic synapse	646
921	87	2.61835926725725	87	0.5963	0.52170495066551	Eukaryotic Translation Termination	513
652	28	0.105773560385862	28	0.5966	0.52170495066551	Adrenaline,noradrenaline inhibits insulin secretion	65
1784	43	0.777916091791561	43	0.5968	0.52170495066551	Transport of Mature mRNAs Derived from Intronless Transcripts*	1780
346	69	1.8191148353361	69	0.5973	0.521708002632321	RNA degradation	1422
1407	166	6.63803928892584	166	0.5978	0.52171104952942	Programmed Cell Death*	1260
547	52	0.91409741799901	52	0.5986	0.521975689610128	Signaling events mediated by Stem cell factor receptor (c-Kit)	1570
1803	15	-0.181611969740103	15	0.5998	0.521995331062193	Unblocking of NMDA receptor, glutamate binding and activation	1818
1763	39	0.624366071591536	39	0.6003	0.521995331062193	Transcriptional activation of mitochondrial biogenesis	1756
612	10	-0.455218274688497	10	0.6005	0.521995331062193	Acetylcholine regulates insulin secretion	15
1826	15	-0.103916257901629	15	0.6012	0.521995331062193	WNT5A-dependent internalization of FZD4	1862
1466	36	0.712292953600094	36	0.6015	0.521995331062193	RNA Polymerase III Transcription Initiation	1447
1704	37	0.488666609465357	37	0.6018	0.521995331062193	TNF signaling	1715
866	22	-0.152970521513314	22	0.6021	0.521995331062193	Diseases associated with the TLR signaling cascade*	411
1306	105	3.40708914035947	105	0.6032	0.522438506234436	O-linked glycosylation	1101
405	47	0.781703736813252	47	0.6045	0.522438506234436	Valine, leucine and isoleucine degradation	1829
1113	10	-0.310173723062965	10	0.6046	0.522438506234436	Interaction With The Zona Pellucida	817
1374	12	-0.230680728106985	12	0.6046	0.522438506234436	Physiological factors	1191
1352	36	0.39088840905674	36	0.6058	0.522890998952044	Paradoxical activation of RAF signaling by kinase inactive BRAF*	1145
1170	36	0.473372122184706	36	0.6062	0.522890998952044	MAP2K and MAPK activation	908
1797	11	-0.39496393554901	11	0.6074	0.522890998952044	Type I hemidesmosome assembly	1808
1479	11	-0.294321144784548	11	0.6083	0.522890998952044	Recruitment of NuMA to mitotic centrosomes	1314
531	71	1.90380362121712	71	0.6084	0.522890998952044	Regulation of nuclear SMAD2/3 signaling	1351
156	93	2.40998186751701	93	0.609	0.522890998952044	Circadian entrainment	286
476	80	1.98595660906623	80	0.6095	0.522890998952044	Glucocorticoid receptor regulatory network	636
305	100	2.72958307402118	100	0.6098	0.522890998952044	Oxidative phosphorylation	1123
1263	108	1.72422969437797	108	0.61	0.522890998952044	Negative epigenetic regulation of rRNA expression*	1027
1470	23	-0.00866756074990864	23	0.6101	0.522890998952044	RNA Polymerase III Transcription Termination	1451
129	68	1.47421407716933	68	0.6107	0.522978660534061	B cell receptor signaling pathway	163
47	23	-0.194969145196631	23	0.6116	0.523068059155508	superpathway of cholesterol biosynthesis	1621
575	22	-0.166864582030376	22	0.6118	0.523068059155508	Visual signal transduction: Rods	1849
1482	22	-0.197568391300325	22	0.6127	0.523411644180691	Recycling pathway of L1	1316
909	41	0.259007839021154	41	0.6138	0.523594091003925	Elastic fibre formation	466
830	44	0.47475358160807	44	0.6151	0.523594091003925	Death Receptor Signalling	370
722	16	-0.343627843292809	16	0.6153	0.523594091003925	CREB phosphorylation through the activation of CaMKII	336
516	19	-0.237079060467763	19	0.6156	0.523594091003925	Paxillin-dependent events mediated by a4b1	1152
1097	128	3.75027696017333	128	0.6159	0.523594091003925	Influenza Viral RNA Transcription and Replication	791
1604	50	0.466260742038948	50	0.616	0.523594091003925	Signaling by ERBB2	1515
1536	93	2.03010516803419	93	0.6165	0.523594091003925	Resolution of Sister Chromatid Cohesion	1386
450	39	0.143445598798522	39	0.6169	0.523594091003925	Class I PI3K signaling events	297
1764	43	0.271430103385475	43	0.6182	0.523772908045566	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1757
854	66	0.109606832189747	66	0.6192	0.523772908045566	Deposition of new CENPA-containing nucleosomes at the centromere*	395
915	17	-0.380768916738302	17	0.6193	0.523772908045566	Ephrin signaling	488
69	16	-0.406651208451937	16	0.6199	0.523772908045566	Hepatitis B virus (dsDNA)	714
1122	41	0.0914587309309189	41	0.6201	0.523772908045566	Interleukin-1 signaling	825
349	204	7.05403203852299	204	0.6202	0.523772908045566	Rap1 signaling pathway	1304
1281	46	-0.0341592608021437	46	0.6206	0.523772908045566	Neurotransmitter Release Cycle	1048
908	11	-0.78609074020273	11	0.6214	0.524027185283718	Eicosanoids	465
1289	108	2.69845958629136	108	0.6219	0.524028267305735	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)*	1072
1705	22	-0.345995218172782	22	0.623	0.5245345172733	TNFR1-induced NFkappaB signaling pathway	1717
1339	29	-0.323648458294937	29	0.6239	0.524871701518982	PIWI-interacting RNA (piRNA) biogenesis	1206
742	585	27.8478571462308	585	0.6256	0.525880424980704	Cell Cycle	243
661	10	-0.522926483978765	10	0.6261	0.525880424980704	Androgen biosynthesis	98
1005	10	-0.731239233666253	10	0.6267	0.525963948411301	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	614
277	22	-0.402616852388243	22	0.6278	0.526466633390084	Mismatch repair	963
917	13	-0.57152942624917	13	0.6285	0.52654489732451	Erythrocytes take up carbon dioxide and release oxygen*	507
1156	13	-0.445083803610363	13	0.6297	0.52654489732451	Leading Strand Synthesis*	872
26	14	-0.637218845270778	14	0.63	0.52654489732451	guanosine nucleotides de novo biosynthesis	692
116	135	3.29749214398669	135	0.6302	0.52654489732451	Apelin signaling pathway	116
1400	10	-0.462898149955898	10	0.6308	0.52654489732451	Processing and activation of SUMO	1252
21	11	-0.643320084887752	11	0.6309	0.52654489732451	gamma-linolenate biosynthesis	615
1517	78	0.454124430980196	78	0.6322	0.526955921306957	Regulation of insulin secretion	1343
747	127	2.35235768421729	127	0.6328	0.526955921306957	Cell surface interactions at the vascular wall	248
958	44	-0.226882321169547	44	0.633	0.526955921306957	Formation of HIV elongation complex in the absence of HIV Tat*	564
765	25	-0.76433612205005	25	0.6336	0.526955921306957	Chylomicron-mediated lipid transport	283
1545	11	-0.869849915543449	11	0.6339	0.526955921306957	Reversible hydration of carbon dioxide	1400
1049	218	7.27745443769743	218	0.635	0.527453053564284	HIV Infection	733
1028	14	-0.767103674290855	14	0.6359	0.527783404738507	Glutathione synthesis and recycling	649
580	29	-0.498308255093928	29	0.639	0.529519814268717	p38 MAPK signaling pathway	1128
1009	29	-0.760934634103869	29	0.639	0.529519814268717	Gap junction trafficking and regulation	620
679	39	-0.456479831730247	39	0.6411	0.530841375613111	Association of TriC/CCT with target proteins during biosynthesis	141
376	55	-0.963713683015279	55	0.6433	0.531819763029426	Steroid hormone biosynthesis	1609
1253	28	-0.825308083652197	28	0.6436	0.531819763029426	NOD1/2 Signaling Pathway	1064
1152	15	-0.803738142666738	15	0.6438	0.531819763029426	LGI-ADAM interactions	878
1845	16	-0.723757051566422	16	0.6446	0.532057078011736	mRNA decay by 3' to 5' exoribonuclease	990
353	59	0.0343190948311397	59	0.6451	0.532057078011736	Renal cell carcinoma	1376
333	32	-0.526073585869333	32	0.6458	0.532216662306186	Propanoate metabolism	1264
49	12	-0.913381105604396	12	0.6466	0.532458343877092	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1624
354	62	-0.0686968091534029	62	0.6492	0.533415013771304	Renin secretion	1377
1688	24	-0.75383213281931	24	0.6492	0.533415013771304	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	1649
1073	124	2.67670466596231	124	0.6498	0.533415013771304	Host Interactions of HIV factors	743
1007	10	-0.727654866705495	10	0.6499	0.533415013771304	Gap junction degradation	618
1096	137	2.74022175513998	137	0.6503	0.533415013771304	Influenza Life Cycle	790
1463	41	-0.35676424485371	41	0.6519	0.534310325534014	RNA Polymerase III Abortive And Retractive Initiation*	1444
843	11	-0.791123591253709	11	0.6533	0.535017901121068	Defects in cobalamin (B12) metabolism	383
3	17	-0.872575730630382	17	0.6541	0.535017901121068	3-phosphoinositide degradation	4
137	19	-1.1640299118475	19	0.6544	0.535017901121068	Biosynthesis of unsaturated fatty acids	190
313	54	-0.397070657843179	54	0.6548	0.535017901121068	Pathogenic Escherichia coli infection	1148
1064	53	-0.337700174624006	53	0.6558	0.535418627641936	Hexose transport	721
619	15	-0.928141748567667	15	0.6571	0.536062089791551	Activation of BAD and translocation to mitochondria	24
620	31	-0.964949986203502	31	0.6596	0.536062089791551	Activation of BH3-only proteins	25
548	36	-0.763894549880765	36	0.6598	0.536062089791551	Signaling events mediated by TCPTP	1571
380	97	0.698944977344456	97	0.6603	0.536062089791551	T cell receptor signaling pathway	1668
738	50	-0.84599016603717	50	0.6604	0.536062089791551	Cargo trafficking to the periciliary membrane	224
81	105	1.1330128759799	97	0.6606	0.536062089791551	Influenza virus (ssRNA)	792
674	57	-0.851668853127279	57	0.6606	0.536062089791551	Arachidonic acid metabolism (REACTOME)	126
545	23	-0.830468710535919	23	0.6617	0.536062089791551	Signaling events mediated by PRL	1568
1760	66	-0.516644499131661	66	0.6619	0.536062089791551	Transcription of the HIV genome	1754
554	21	-1.21073650680822	21	0.6621	0.536062089791551	Sphingosine 1-phosphate (S1P) pathway	1598
772	348	11.33010993462	348	0.6622	0.536062089791551	Class I MHC mediated antigen processing & presentation	296
1273	35	-0.893394312733535	35	0.6649	0.537265720114978	Negative regulators of RIG-I/MDA5 signaling	1037
1767	35	-1.0705325480954	35	0.6649	0.537265720114978	Transcriptional regulation of pluripotent stem cells	1762
1094	17	-0.900328729501333	17	0.666	0.537265720114978	Inflammasomes	785
1841	10	-1.13502740904897	10	0.6667	0.537265720114978	mRNA Editing	992
1279	10	-0.923189963390309	10	0.667	0.537265720114978	Neurotoxicity of clostridium toxins	1046
1783	68	-0.123397539870205	68	0.6672	0.537265720114978	Transport of Mature mRNA derived from an Intron-Containing Transcript	1778
912	28	-1.18819621560645	28	0.6679	0.537265720114978	Endosomal Sorting Complex Required For Transport (ESCRT)	473
40	10	-1.14226552821235	10	0.6683	0.537265720114978	pyrimidine deoxyribonucleotide phosphorylation	1288
771	39	-2.28706455107409	39	0.6683	0.537265720114978	Class C/3 (Metabotropic glutamate/pheromone receptors)	295
555	39	-0.908127622268535	39	0.6688	0.537265720114978	Stabilization and expansion of the E-cadherin adherens junction	1603
11	10	-1.18619309483363	10	0.6694	0.537336908839174	UTP and CTP de novo biosynthesis	1823
1673	97	0.705512287682866	97	0.6717	0.537432978361967	Synthesis of DNA	1650
1219	48	-1.06324408731491	48	0.6718	0.537432978361967	Mitochondrial biogenesis	968
469	33	-1.45400495493559	33	0.6722	0.537432978361967	FAS (CD95) signaling pathway	521
678	66	-0.548946694249436	66	0.6723	0.537432978361967	Assembly of the pre-replicative complex	139
739	27	-1.2905953438479	27	0.6725	0.537432978361967	Caspase activation via extrinsic apoptotic signalling pathway	226
1157	17	-1.17101418337787	17	0.673	0.537432978361967	Ligand-dependent caspase activation	879
1182	10	-0.980253203567506	10	0.6731	0.537432978361967	MET receptor recycling	931
701	10	-1.00500872313726	10	0.6777	0.540091780342068	Biotin transport and metabolism	191
855	22	-1.35913877208134	22	0.6782	0.540091780342068	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models*	396
1600	57	-0.986842082494922	57	0.6784	0.540091780342068	Signaling by BRAF and RAF fusions	1510
1834	13	-1.30767998881556	13	0.6787	0.540091780342068	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism*	79
1687	15	-1.42813676755483	15	0.679	0.540091780342068	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1648
1233	21	-1.35438971568528	21	0.6807	0.541034434053544	Mitotic Spindle Checkpoint*	984
680	15	-1.34727170972321	15	0.6828	0.541633398917574	Association of licensing factors with the pre-replicative complex	140
1325	11	-1.22895008271367	11	0.6828	0.541633398917574	PECAM1 interactions	1159
734	113	0.468825105339695	113	0.683	0.541633398917574	Cap-dependent Translation Initiation*	217
828	22	-1.45191613624902	22	0.6845	0.542296039934442	Deadenylation of mRNA	368
1006	18	-1.84867231856027	18	0.6851	0.542296039934442	Gap junction assembly	617
737	91	-0.269908554780249	91	0.6858	0.542296039934442	Cargo recognition for clathrin-mediated endocytosis	223
844	17	-1.22566692318601	17	0.6859	0.542296039934442	Defects in vitamin and cofactor metabolism	384
1550	123	0.827644660103272	123	0.6886	0.543900618229658	S Phase	1462
1812	12	-1.30496439735491	12	0.689	0.543900618229658	VLDLR internalisation and degradation	1853
227	13	-1.52872092702466	13	0.6898	0.543900618229658	Guanine ribonucleotide biosynthesis IMP => GDP,GTP	690
632	10	-1.35969983593298	10	0.69	0.543900618229658	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	38
708	21	-1.72952946875291	21	0.691	0.544280567491464	CD209 (DC-SIGN) signaling	229
461	32	-1.73909142404625	32	0.6917	0.544423823286178	EPHB forward signaling	485
65	35	-2.28183799624607	31	0.694	0.545607381428589	Dengue Fever Virus (ssRNA)	392
1083	12	-1.34133000900027	12	0.6952	0.545607381428589	IRF3-mediated induction of type I IFN	848
1864	38	-1.52780831174663	38	0.6956	0.545607381428589	tRNA modification in the nucleus and cytosol	1798
1761	78	-1.18353431070739	78	0.6957	0.545607381428589	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1755
744	488	15.8813601190734	488	0.6958	0.545607381428589	Cell Cycle, Mitotic	245
118	31	-1.79829300657238	31	0.6967	0.545905718683401	Apoptosis - multiple species	117
1475	18	-1.63720573940714	18	0.6975	0.546125313786306	Ras activation uopn Ca2+ infux through NMDA receptor	1306
1050	140	0.53877286518567	140	0.6992	0.547048734987444	HIV Life Cycle	734
715	57	-1.57688844348337	57	0.7008	0.547468820392601	CDT1 association with the CDC6:ORC:origin complex	240
322	90	-1.1245149676842	90	0.7013	0.547468820392601	Phosphatidylinositol signaling system	1179
1495	26	-3.10459936701735	26	0.7013	0.547468820392601	Regulation of IFNA signaling	1340
1383	17	-1.67767459245664	17	0.7022	0.547759369464213	Polo-like kinase mediated events	1225
624	40	-2.10523585074364	40	0.7035	0.547759369464213	Activation of GABAB receptors*	29
371	16	-1.72473753995848	16	0.704	0.547759369464213	Sphingosine biosynthesis	1599
960	41	-2.09385753409321	41	0.7041	0.547759369464213	Formation of Incision Complex in GG-NER	566
1490	74	-1.33952415405291	74	0.7044	0.547759369464213	Regulation of DNA replication*	1333
660	93	-1.00568823341689	93	0.7048	0.547759369464213	Anchoring of the basal body to the plasma membrane	97
27	11	-1.69863385086422	11	0.7056	0.547936750310972	guanosine ribonucleotides de novo biosynthesis	693
752	85	-1.12770645766433	85	0.7062	0.547936750310972	Cellular response to heat stress	252
553	34	-1.85517812279694	34	0.7067	0.547936750310972	Signaling mediated by p38-alpha and p38-beta	1575
328	17	-1.64939342943979	17	0.7079	0.547936750310972	Primary bile acid biosynthesis	1249
572	60	-1.59193669107029	60	0.7084	0.547936750310972	Validated targets of C-MYC transcriptional repression	1826
1513	53	-1.93442700983765	53	0.7086	0.547936750310972	Regulation of cholesterol biosynthesis by SREBP (SREBF)	1330
117	132	-0.831434489046787	132	0.7091	0.547936750310972	Apoptosis (KEGG)	118
239	168	1.02656607731695	168	0.7092	0.547936750310972	Huntington's disease	757
957	37	-2.37914299483171	37	0.7105	0.548537809872478	Formation of Fibrin Clot (Clotting Cascade)	563
1694	12	-1.60148753271152	12	0.7115	0.548906543443408	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1666
1686	14	-1.97955615594603	14	0.7122	0.549043462379572	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1647
1081	10	-1.69307434657794	10	0.713	0.549233040933894	IRAK4 deficiency (TLR2/4)*	846
1228	137	0.123856487128195	137	0.7146	0.549233040933894	Mitotic G1-G1/S phases	979
343	11	-1.84550222603624	11	0.7153	0.549233040933894	Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP	1293
886	65	-2.18893070209089	65	0.7164	0.549233040933894	Dual incision in TC-NER	448
1303	44	-2.35094241073708	44	0.7169	0.549233040933894	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1097
776	21	-2.05442588420869	21	0.7174	0.549233040933894	Cobalamin (Cbl, vitamin B12) transport and metabolism	304
1008	27	-2.60317111254051	27	0.7176	0.549233040933894	Gap junction trafficking	619
1860	174	0.648773619820077	174	0.7179	0.549233040933894	rRNA processing*	1459
7	12	-1.56880185496248	12	0.7184	0.549233040933894	D-myo-inositol (1,4,5)-trisphosphate degradation	360
1074	40	-2.16919517029348	40	0.7185	0.549233040933894	Host Interactions with Influenza Factors*	744
1621	19	-2.17356659869049	19	0.7195	0.549233040933894	Signaling by Hippo	1533
822	104	-1.19843469382846	104	0.7208	0.549233040933894	DNA Replication	426
956	10	-1.63658215992337	10	0.721	0.549233040933894	Folding of actin by CCT/TriC	561
1011	64	-2.3891074211505	64	0.721	0.549233040933894	Gap-filling DNA repair synthesis and ligation in TC-NER	622
224	28	-2.01177270394154	28	0.7214	0.549233040933894	Glyoxylate and dicarboxylate metabolism	674
427	15	-1.98226770538698	15	0.7216	0.549233040933894	Arf6 downstream pathway	128
428	34	-2.49802140365826	34	0.722	0.549233040933894	Arf6 signaling events	129
1158	20	-3.05397285849804	20	0.722	0.549233040933894	Ligand-gated ion channel transport	880
633	10	-1.71936053022257	10	0.7229	0.549233040933894	Activation of PUMA and translocation to mitochondria	39
1639	47	-2.42443353814663	47	0.7229	0.549233040933894	Signaling by RAS mutants	1552
149	12	-1.87079258252065	12	0.7239	0.54959541079845	Ceramide biosynthesis	259
1315	10	-1.7470176319021	10	0.7245	0.549653790834037	Organic anion transporters	1113
1016	812	19.5350469675494	812	0.7264	0.55069764132666	Generic Transcription Pathway	628
92	16	-1.98959744651787	16	0.7271	0.550830899734813	2-Oxocarboxylic acid metabolism	2
1542	14	-2.02171991936629	14	0.7297	0.552231563311212	Retrograde neurotrophin signalling	1397
199	81	-3.07540591494475	81	0.73	0.552231563311212	GABAergic synapse	611
665	291	4.06988210879207	291	0.7328	0.553738498540226	Antigen processing: Ubiquitination & Proteasome degradation	105
1572	14	-1.92004173609176	14	0.7334	0.553738498540226	STING mediated induction of host immune responses	1611
1768	83	-2.6134046654312	83	0.734	0.553738498540226	Transcriptional regulation of white adipocyte differentiation	1763
687	23	-2.60683843373857	23	0.7341	0.553738498540226	BBSome-mediated cargo-targeting to cilium	173
770	88	-2.81411037124771	88	0.7349	0.553944283223327	Class B/2 (Secretin family receptors)	294
969	48	-2.866884367435	48	0.7366	0.55399239723639	Formation of the ternary complex, and subsequently, the 43S complex	574
1023	45	-2.91182140156239	45	0.7369	0.55399239723639	Glucose transport	641
1417	12	-2.19566995864472	12	0.7371	0.55399239723639	Purine ribonucleoside monophosphate biosynthesis	1285
537	20	-2.42061737312972	20	0.7375	0.55399239723639	S1P1 pathway	1463
922	31	-2.6398726418768	31	0.7376	0.55399239723639	Export of Viral Ribonucleoproteins from Nucleus*	514
1791	37	-3.16893546382096	37	0.7384	0.554197118628923	Transport of vitamins, nucleosides, and related molecules	1786
458	25	-2.52616639061617	25	0.74	0.554414368319687	EGF receptor (ErbB1) signaling pathway	460
1578	17	-2.27511483548565	17	0.7402	0.554414368319687	SUMOylation of transcription factors	1620
291	15	-2.58971976370166	15	0.7407	0.554414368319687	Nitrogen metabolism	1062
121	18	-2.36388472422145	18	0.7408	0.554414368319687	Arginine biosynthesis	132
530	19	-2.42464142981929	19	0.7416	0.554618060831048	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	1332
1134	20	-2.68745624257819	20	0.7432	0.555217254722575	Intrinsic Pathway of Fibrin Clot Formation	839
515	40	-3.21875935870907	40	0.7448	0.555217254722575	PLK1 signaling events	1224
961	57	-3.78070472498509	57	0.7448	0.555217254722575	Formation of RNA Pol II elongation complex*	567
1674	10	-1.84388761118517	10	0.745	0.555217254722575	Synthesis of IP2, IP, and Ins in the cytosol	1652
1693	19	-2.63680907921245	19	0.7454	0.555217254722575	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1665
1366	10	-1.91346233440352	10	0.7456	0.555217254722575	Phenylalanine and tyrosine catabolism	1177
75	33	-3.58206593695658	28	0.7461	0.555217254722575	Human Immunodeficiency Virus type 1 (dsDNA)	751
30	11	-2.05721440775957	11	0.7496	0.557427033924594	isoleucine degradation	853
1844	50	-3.21247748415317	50	0.7506	0.55760450724309	mRNA Splicing - Minor Pathway	995
707	11	-2.17321416014656	11	0.7509	0.55760450724309	CASP8 activity is inhibited*	225
1285	22	-2.79359642813315	22	0.7517	0.557804364474404	Nitric oxide stimulates guanylate cyclase	1061
618	37	-3.25888820113922	37	0.7526	0.558078092968162	Activation of ATR in response to replication stress	23
1307	63	-3.75729834822281	63	0.7551	0.559537052235248	O-linked glycosylation of mucins	1102
874	29	-3.41864921634197	29	0.7575	0.560377002742192	Downregulation of ERBB2 signaling	432
236	28	-3.23842135263392	28	0.7581	0.560377002742192	Hippo signaling pathway -multiple species	729
361	32	-3.373684805821	32	0.7584	0.560377002742192	SNARE interactions in vesicular transport	1590
1435	17	-2.72135324393277	17	0.7597	0.560377002742192	RHO GTPases activate CIT	1404
318	80	-3.2131016050039	80	0.76	0.560377002742192	Peroxisome	1169
251	148	-4.9047301457955	148	0.7602	0.560377002742192	Jak-STAT signaling pathway	854
574	21	-2.99735573804576	21	0.7605	0.560377002742192	Visual signal transduction: Cones	1848
1311	71	-3.95443697845025	71	0.7605	0.560377002742192	Oncogenic MAPK signaling	1107
279	85	-4.2912301317293	85	0.7613	0.560573376494148	Morphine addiction	987
491	37	-3.79865657054466	37	0.763	0.561112360767957	IL23-mediated signaling events	774
52	13	-2.43598260559083	13	0.7631	0.561112360767957	superpathway of methionine degradation	1627
634	12	-2.43831722630547	12	0.7642	0.561209271179304	Activation of Rac	40
640	56	-3.61869610344969	57	0.7643	0.561209271179304	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S*	43
246	22	-3.24505064232368	22	0.7653	0.561232585683468	Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4	803
1	14	-2.49109601636073	14	0.7654	0.561232585683468	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1
1133	43	-3.85556876200819	43	0.7673	0.562233421100432	Intrinsic Pathway for Apoptosis	838
759	22	-3.4544269632221	22	0.7699	0.563745424031403	Cholesterol biosynthesis	270
1484	15	-2.99468725613343	15	0.7715	0.564523599010187	Regulated Necrosis*	1319
1598	13	-2.72140782938473	13	0.7737	0.565565208979364	Signaling by Activin	1508
702	21	-3.2355592048263	21	0.774	0.565565208979364	Branched-chain amino acid catabolism	195
496	29	-3.71104871053242	29	0.7754	0.566102201126462	Insulin-mediated glucose transport	811
786	24	-3.52221024751607	24	0.7776	0.566102201126462	Constitutive Signaling by AKT1 E17K in Cancer	319
670	11	-2.81636308229097	11	0.7781	0.566102201126462	Apoptotic cleavage of cell adhesion proteins	121
1799	205	-5.08941861748044	205	0.7784	0.566102201126462	Ub-specific processing proteases	1811
540	14	-2.85700885786997	14	0.7785	0.566102201126462	S1P4 pathway	1466
1088	112	-9.0748978479195	112	0.7788	0.566102201126462	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	779
630	37	-4.12997239435687	37	0.7802	0.566102201126462	Activation of NMDA receptor upon glutamate binding and postsynaptic events	37
1590	15	-3.04674459388284	15	0.7802	0.566102201126462	Serotonin Neurotransmitter Release Cycle	1490
1796	11	-2.78967640235221	11	0.7805	0.566102201126462	Tryptophan catabolism	1804
1294	50	-4.16192413619294	50	0.781	0.566102201126462	Nuclear Envelope Breakdown	1087
1455	77	-4.92449107753465	77	0.7811	0.566102201126462	RNA Polymerase II Pre-transcription Events	1435
324	27	-3.94545474147883	27	0.7812	0.566102201126462	Phototransduction	1190
215	19	-3.26782710835604	19	0.7826	0.566725875768601	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	663
1675	27	-3.83883374029144	27	0.7838	0.566800380462898	Synthesis of IP3 and IP4 in the cytosol	1653
448	43	-4.47693114240447	43	0.7843	0.566800380462898	Ceramide signaling pathway	260
641	11	-2.58239090937853	11	0.7844	0.566800380462898	Activation of the phototransduction cascade	44
994	52	-5.57138104553739	52	0.785	0.566800380462898	GABA receptor activation	609
638	10	-2.51436211746227	10	0.7854	0.566800380462898	Activation of the AP-1 family of transcription factors	42
292	140	-4.38252123938041	140	0.7887	0.568791241341426	Non-alcoholic fatty liver disease (NAFLD)	1065
1496	14	-2.98314184495344	14	0.7895	0.56880374699197	Regulation of IFNG signaling	1341
1816	42	-4.46468394360462	42	0.7898	0.56880374699197	Viral Messenger RNA Synthesis	1844
365	107	-5.62819393466685	107	0.7912	0.569421726690517	Serotonergic synapse	1489
1106	44	-4.59523578912909	44	0.7919	0.56953541959041	Inositol phosphate metabolism (REACTOME)	802
1143	18	-3.49643381932003	18	0.7932	0.569834160917161	KSRP (KHSRP) binds and destabilizes mRNA	865
608	10	-3.05201352812215	10	0.7934	0.569834160917161	Abacavir transport and metabolism	7
1413	58	-5.47799857156674	58	0.7952	0.570244907145607	Protein ubiquitination	1273
1387	34	-4.44380908802566	34	0.7953	0.570244907145607	Post NMDA receptor activation events	1231
980	29	-4.60845616663564	29	0.7956	0.570244907145607	G-protein activation	595
480	34	-4.67247752605087	34	0.7966	0.5705724518125	HIV-1 Nef: Negative effector of Fas and TNF-alpha	737
383	79	-7.81255199116661	79	0.7983	0.571400590460389	Taste transduction	1672
432	37	-4.49809482054106	37	0.8004	0.571997390653401	Aurora B signaling	153
1151	23	-3.9681149193318	23	0.8008	0.571997390653401	LDL-mediated lipid transport	871
586	17	-3.95992378906905	17	0.8015	0.571997390653401	ABC transporters in lipid homeostasis	10
522	10	-2.75475825227675	10	0.8016	0.571997390653401	Ras signaling in the CD4+ TCR pathway	1307
198	30	-4.78198358317763	30	0.8023	0.571997390653401	Fructose and mannose metabolism	586
760	19	-3.89342465838707	19	0.8024	0.571997390653401	Chondroitin sulfate biosynthesis	277
873	19	-4.09438135682915	19	0.8039	0.572574921677996	Dopamine Neurotransmitter Release Cycle	429
134	12	-3.08808968799604	12	0.8043	0.572574921677996	Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate	183
344	38	-4.8695269908015	38	0.805	0.57262127409306	Pyruvate metabolism (KEGG)	1294
1194	278	-1.99394140628437	278	0.806	0.57262127409306	Metabolism of carbohydrates	936
1521	13	-3.51123743418372	13	0.806	0.57262127409306	Regulation of necroptotic cell death	1350
188	42	-5.88182216151237	42	0.8068	0.572802342385418	Fatty acid degradation	526
311	18	-3.91366186463133	18	0.8076	0.572861737169458	Pantothenate and CoA biosynthesis	1144
360	85	-7.58572410339157	85	0.8084	0.572861737169458	Ribosome biogenesis in eukaryotes	1416
963	53	-5.53017676670858	53	0.8089	0.572861737169458	Formation of TC-NER Pre-Incision Complex	569
740	12	-3.26778832645052	12	0.8096	0.572861737169458	Caspase-mediated cleavage of cytoskeletal proteins	228
823	81	-5.76349047880828	81	0.8097	0.572861737169458	DNA Replication Pre-Initiation*	427
312	109	-6.18171281068348	109	0.8106	0.572861737169458	Parkinson's disease	1146
501	63	-6.13013394622886	63	0.8107	0.572861737169458	LPA receptor mediated events	894
172	66	-10.2831671464742	66	0.8122	0.573535976190324	Drug metabolism - cytochrome P450	444
981	48	-5.7211958321935	48	0.8138	0.573964974871218	G-protein beta:gamma signalling	596
317	10	-2.93104880101656	10	0.8139	0.573964974871218	Pentose phosphate pathway (Pentose phosphate cycle)	1162
1703	16	-4.02048279090188	16	0.8146	0.574040694422446	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1714
167	61	-7.65917233864721	61	0.8151	0.574040694422446	Cytosolic DNA-sensing pathway	353
62	12	-3.2120681771093	12	0.8163	0.574224178362474	valine degradation	1828
451	33	-5.14171399134584	33	0.8169	0.574224178362474	Class I PI3K signaling events mediated by Akt	298
1292	16	-3.96177339466347	16	0.817	0.574224178362474	Norepinephrine Neurotransmitter Release Cycle	1076
1135	31	-5.53146250120451	31	0.8185	0.574893901104356	Inwardly rectifying K+ channels	840
357	95	-7.73743642387612	95	0.8198	0.574975922786913	Retrograde endocannabinoid signaling	1396
5	14	-3.68235135483259	14	0.8211	0.574975922786913	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	358
48	32	-5.11488288858182	32	0.8214	0.574975922786913	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	1622
245	67	-6.35647728341238	67	0.8217	0.574975922786913	Inositol phosphate metabolism (KEGG)	801
326	71	-7.74992657532526	71	0.8217	0.574975922786913	Platinum drug resistance	1221
316	25	-4.62585017530056	25	0.8219	0.574975922786913	Pentose phosphate pathway	1161
983	25	-4.84932039230713	25	0.8225	0.575012832858303	G0 and Early G1	598
66	16	-3.96657303236035	16	0.8254	0.576656563359786	Ebola Virus (ssRNA)	456
1566	11	-3.40135761666356	11	0.8268	0.576868934765792	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1584
1185	159	-6.64478880630021	159	0.8273	0.576868934765792	Major pathway of rRNA processing in the nucleolus and cytosol	904
46	19	-4.20467117033382	19	0.8276	0.576868934765792	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1623
1161	70	-7.16479418370384	70	0.8279	0.576868934765792	Lipoprotein metabolism	884
267	26	-5.10491666427439	26	0.8296	0.577253481191573	Maturity onset diabetes of the young	917
1422	45	-6.36993157800571	45	0.8301	0.577253481191573	Pyruvate metabolism and Citric Acid (TCA) cycle	1296
1709	78	-7.06378551926296	78	0.8301	0.577253481191573	TP53 Regulates Metabolic Genes	1733
301	123	-8.37778844107153	123	0.8312	0.577636136446622	Osteoclast differentiation	1116
468	32	-5.56278973254796	32	0.8333	0.578712768980567	ErbB4 signaling events	503
204	95	-7.80865909930818	95	0.8351	0.579231020123975	Glucagon signaling pathway	633
977	45	-6.49932674979582	45	0.8352	0.579231020123975	G beta:gamma signalling through PI3Kgamma	592
415	12	-3.92010729049089	12	0.8357	0.579231020123975	beta-Oxidation	179
1523	12	-3.82154699264549	12	0.8367	0.57939939862484	Regulation of pyruvate dehydrogenase (PDH) complex	1355
1567	10	-3.33605800290663	10	0.8378	0.57939939862484	SLBP independent Processing of Histone Pre-mRNAs	1585
627	31	-5.77933981953655	31	0.8382	0.57939939862484	Activation of Kainate Receptors upon glutamate binding	33
992	10	-4.56758660321878	10	0.8384	0.57939939862484	GABA A receptor activation	607
252	53	-6.88247009626931	53	0.8387	0.57939939862484	Legionellosis	873
568	28	-5.53811189706628	28	0.8397	0.57963778948513	Trk receptor signaling mediated by the MAPK pathway	1796
1026	23	-5.17863980329148	23	0.8402	0.57963778948513	Glutamate Neurotransmitter Release Cycle	645
1092	22	-5.08118154280839	22	0.8407	0.57963778948513	Incretin synthesis, secretion, and inactivation	783
731	10	-3.73780346042683	10	0.843	0.58084244126055	Calcitonin-like ligand receptors	208
331	86	-7.93641002522753	86	0.8484	0.583552970778677	Progesterone-mediated oocyte maturation	1259
1469	28	-5.60988698201876	28	0.8485	0.583552970778677	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1450
1448	31	-6.24064948033947	32	0.8486	0.583552970778677	RNA Polymerase I Promoter Escape*	1428
147	121	-7.92348992834685	121	0.8496	0.583858529943294	Cell cycle	242
773	68	-7.63374336068812	68	0.8517	0.584002460488645	Clathrin derived vesicle budding*	299
356	59	-11.4804495913823	59	0.8518	0.584002460488645	Retinol metabolism	1395
1155	127	-8.7296494450851	127	0.8529	0.584002460488645	Late Phase of HIV Life Cycle	870
108	147	-8.18790153428844	147	0.853	0.584002460488645	Alzheimer's disease	83
1071	11	-4.02209042784613	11	0.8533	0.584002460488645	Hormone ligand-binding receptors	741
1036	24	-5.69633543727493	24	0.8536	0.584002460488645	Glyoxylate metabolism and glycine degradation	675
283	13	-4.42017369802173	13	0.8537	0.584002460488645	N-glycan precursor biosynthesis	1017
285	161	-11.6587261745642	161	0.8554	0.58478468399315	NOD-like receptor signaling pathway	1063
345	65	-10.7297775679979	65	0.8577	0.585975806920983	RIG-I-like receptor signaling pathway	1417
1493	67	-7.88950668004045	67	0.8586	0.586209531309033	Regulation of HSF1-mediated heat shock response	1338
1794	17	-5.0110082208335	17	0.8624	0.588326367222879	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1794
1116	33	-6.58187685105593	33	0.863	0.588326367222879	Interactions of Vpr with host cellular proteins*	820
1030	14	-4.80335879024138	14	0.8636	0.588326367222879	Glycogen breakdown (glycogenolysis)	655
1038	14	-4.54419882819471	14	0.8644	0.588326367222879	Golgi Cisternae Pericentriolar Stack Reorganization	679
667	75	-8.49829976314273	75	0.8645	0.588326367222879	Antiviral mechanism by IFN-stimulated genes*	107
290	35	-8.21298079922547	35	0.8653	0.588489652646542	Nicotine addiction	1059
1040	25	-6.80839510200915	25	0.8672	0.589400351819222	Growth hormone receptor signaling	688
623	25	-6.76409946182735	25	0.8692	0.590377795591127	Activation of G protein gated Potassium channels*	28
929	13	-4.92455627076917	13	0.8706	0.590904377245373	FCGR activation	541
538	23	-6.39350546409949	23	0.8711	0.590904377245373	S1P2 pathway	1464
1027	38	-9.67161924356669	38	0.8731	0.591565094463822	Glutathione conjugation	647
31	12	-4.44032962070289	12	0.8732	0.591565094463822	leucine degradation	875
1575	73	-9.62397997890678	73	0.8772	0.593780279730002	SUMOylation of DNA damage response and repair proteins	1617
19	13	-4.99189400839778	13	0.8776	0.593780279730002	fatty acid beta-oxidation	523
254	13	-4.71618517610298	13	0.8783	0.593871493870095	Leucine degradation, leucine => acetoacetate + acetyl-CoA	876
1720	16	-5.64858339382773	16	0.8814	0.595584331554927	TRAF3-dependent IRF activation pathway	1744
914	27	-7.19239162858995	27	0.8838	0.596573919842617	Energy dependent regulation of mTOR by LKB1-AMPK	476
611	16	-5.66995205832743	16	0.884	0.596573919842617	Acetylcholine Neurotransmitter Release Cycle	14
723	26	-6.94997472721949	26	0.885	0.596865433972037	CREB phosphorylation through the activation of Ras	337
71	18	-6.53542450430501	16	0.8859	0.5970891749638	Hepatitis C Virus (dsDNA)	717
45	11	-5.24441209712481	11	0.8896	0.59901667873317	stearate biosynthesis	1607
1848	21	-6.78691575321837	21	0.8899	0.59901667873317	mTORC1-mediated signalling	1000
1043	20	-6.67058771433471	20	0.8927	0.59942506313551	HDL-mediated lipid transport	696
1052	44	-9.06482724639522	44	0.8932	0.59942506313551	HIV Transcription Initiation*	736
1332	77	-11.4331509161964	77	0.8933	0.59942506313551	PI3K Cascade	1197
17	15	-5.83381527764493	15	0.8935	0.59942506313551	chondroitin sulfate biosynthesis	276
1297	34	-8.05449683826711	34	0.8938	0.59942506313551	Nuclear Pore Complex (NPC) Disassembly	1091
539	28	-8.09006671605465	28	0.8945	0.59942506313551	S1P3 pathway	1465
1424	82	-11.1984324981278	82	0.8945	0.59942506313551	RAB GEFs exchange GTP for GDP on RABs	1298
1408	16	-6.81354761289436	16	0.896	0.600047564306371	Prolactin receptor signaling	1261
393	99	-15.0163277912286	99	0.8974	0.600602345543673	Toll-like receptor signaling pathway	1730
583	54	-10.0142982799816	54	0.8989	0.600697105589843	p75(NTR)-mediated signaling	1138
673	51	-10.3294933779592	51	0.8994	0.600697105589843	Aquaporin-mediated transport	124
1544	33	-8.17668734175627	33	0.8999	0.600697105589843	Rev-mediated nuclear export of HIV RNA	1399
1235	30	-7.98088013903166	30	0.9001	0.600697105589843	Molecules associated with elastic fibres	986
1721	35	-11.8341535764643	35	0.9004	0.600697105589843	TRAF6 mediated IRF7 activation	1747
1813	42	-9.64049284625446	42	0.9022	0.60074356519366	Vasopressin regulates renal water homeostasis via Aquaporins	1832
579	60	-10.417065996331	60	0.9024	0.60074356519366	mTOR signaling pathway (PID)	998
590	13	-5.91480608155745	13	0.9027	0.60074356519366	AKT phosphorylates targets in the cytosol	71
1444	27	-7.99377842407747	27	0.903	0.60074356519366	RNA Pol II CTD phosphorylation and interaction with CE*	1423
272	72	-18.4122561827621	72	0.9038	0.60074356519366	Metabolism of xenobiotics by cytochrome P450	949
1018	33	-8.61457499688129	33	0.9039	0.60074356519366	Glucagon signaling in metabolic regulation	632
1742	32	-9.11550430380793	32	0.9047	0.600895182628293	Thrombin signalling through proteinase activated receptors (PARs)	1703
783	48	-10.1155534725709	48	0.9059	0.601312117775195	Complex I biogenesis	315
1733	25	-9.02297699320671	25	0.9076	0.602060203551166	Termination of O-glycan biosynthesis	1684
1492	30	-8.46254244937703	30	0.9092	0.60274105180985	Regulation of Glucokinase by Glucokinase Regulatory Protein	1337
1574	105	-14.0166051321924	105	0.9122	0.604348566153246	SUMOylation	1615
1512	33	-9.67108765295042	33	0.9163	0.605914403448405	Regulation of beta-cell development	1328
1840	29	-8.81998570331338	29	0.9164	0.605914403448405	mRNA Capping	989
18	12	-5.97711179441078	12	0.9167	0.605914403448405	dermatan sulfate biosynthesis	397
1032	30	-8.89533979962595	30	0.9183	0.605914403448405	Glycolysis	658
589	23	-8.59010848607318	23	0.9184	0.605914403448405	ADP signalling through P2Y purinoceptor 12	64
888	10	-5.61941386110863	10	0.9185	0.605914403448405	E2F-enabled inhibition of pre-replication complex formation	453
704	17	-6.94033750625225	17	0.9186	0.605914403448405	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	199
68	149	-17.2931318954752	136	0.9202	0.606588989577714	Epstein-Barr Virus (dsDNA)	492
856	10	-5.7372342153597	10	0.9215	0.606750566098838	Dermatan sulfate biosynthesis	398
1397	21	-8.26252446443615	21	0.9216	0.606750566098838	Presynaptic function of Kainate receptors*	1246
1020	30	-9.7778104810109	30	0.9234	0.607372017931195	Glucagon-type ligand receptors	635
1594	33	-10.8670825529927	33	0.9237	0.607372017931195	Signal amplification	1501
455	19	-7.87003537624913	19	0.9244	0.607452164920253	E-cadherin signaling in keratinocytes	449
201	85	-14.4298702927606	85	0.9271	0.608845652892423	Gap junction	616
1022	76	-13.0708780910304	76	0.9278	0.608924779313749	Glucose metabolism	640
151	78	-23.0505177411248	78	0.9293	0.609213834294995	Chemical carcinogenesis	265
1777	62	-14.0346544560352	62	0.9294	0.609213834294995	Translocation of GLUT4 to the plasma membrane	1772
1789	34	-9.96227880584008	34	0.9307	0.609685632910473	Transport of the SLBP Dependant Mature mRNA*	1784
997	932	-39.1810085765553	925	0.9316	0.609894973724941	GPCR downstream signaling	681
1218	21	-8.99436379183318	21	0.9335	0.61044364573459	Mitochondrial Fatty Acid Beta-Oxidation	969
1220	52	-12.2920544557412	52	0.9336	0.61044364573459	Mitochondrial protein import	970
136	65	-12.7777553132124	65	0.9342	0.610456088591775	Biosynthesis of amino acids	188
797	10	-6.54254006809451	10	0.9349	0.610533820701683	Creatine metabolism	334
1684	26	-9.54463048876073	26	0.9366	0.611264097823554	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1645
1166	34	-10.8703333665215	34	0.9376	0.611536902811546	Lysosome Vesicle Biogenesis	900
1573	99	-16.8093745337189	99	0.9389	0.612004918885188	SUMO E3 ligases SUMOylate target proteins	1614
213	63	-16.1086270499664	63	0.9408	0.61264679386734	Glycolysis / Gluconeogenesis	660
756	95	-16.8136181941272	95	0.9417	0.61264679386734	Chaperonin-mediated protein folding	264
1019	42	-12.3819558735703	42	0.9417	0.61264679386734	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	634
1365	106	-24.8556501305538	106	0.9426	0.61264679386734	Phase II conjugation	1176
622	13	-7.75478551435127	13	0.9428	0.61264679386734	Activation of DNA fragmentation factor*	27
194	138	-19.9977325290068	138	0.9434	0.612657798172791	Fluid shear stress and atherosclerosis	558
1515	21	-9.66303808609834	21	0.9453	0.613512506496099	Regulation of gene expression in beta cells	1336
1411	101	-17.7542793126068	101	0.9476	0.614570546718645	Protein folding	1270
1147	212	-57.6882246804986	212	0.9481	0.614570546718645	Keratinization	863
1056	11	-7.42660046435324	11	0.949	0.614590116913801	HSF1 activation	747
1757	12	-8.05830488049463	12	0.9493	0.614590116913801	Trafficking and processing of endosomal TLR	1749
296	43	-13.260077788483	43	0.9506	0.615052794682648	Nucleotide excision repair	1095
1538	93	-17.260945617296	93	0.9514	0.615191594407017	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1388
657	26	-10.5352057955109	26	0.9526	0.615257048549027	Amino acid synthesis and interconversion (transamination)	88
1537	88	-17.1829175080419	88	0.9532	0.615257048549027	Respiratory electron transport	1387
22	13	-8.4078354422305	13	0.9545	0.615257048549027	gluconeogenesis	637
1683	15	-8.79410519214624	15	0.9551	0.615257048549027	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1661
975	139	-22.4760897235916	139	0.9553	0.615257048549027	G alpha (s) signalling events	590
1327	74	-17.4756273627432	74	0.9553	0.615257048549027	PI Metabolism	1192
1681	13	-8.44135169324089	13	0.9556	0.615257048549027	Synthesis of PIPs at the early endosome membrane	1658
1549	24	-11.5757691299416	24	0.9577	0.615983007943092	Role of phospholipids in phagocytosis	1455
1421	25	-11.8279521285384	25	0.9579	0.615983007943092	Pyruvate metabolism (REACTOME)	1295
1576	45	-14.5356565394461	45	0.9594	0.616091256298228	SUMOylation of DNA replication proteins	1618
588	25	-12.3946463343882	25	0.9602	0.616091256298228	ADP signalling through P2Y purinoceptor 1	63
1473	32	-12.708773254109	32	0.9602	0.616091256298228	ROS, RNS production in phagocytes	1457
642	30	-11.9721725592039	30	0.9605	0.616091256298228	Activation of the pre-replicative complex	45
837	17	-11.8923691283334	17	0.961	0.616091256298228	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)*	377
706	137	-23.7307102612435	137	0.9625	0.616300852207809	C-type lectin receptors (CLRs)	203
1115	35	-12.7994366596407	35	0.9625	0.616300852207809	Interactions of Rev with host cellular proteins	819
144	103	-19.8213307873313	103	0.9643	0.617077377438048	Carbon metabolism	219
1299	32	-12.7551288421549	32	0.9651	0.617165643967711	Nuclear import of Rev protein	1090
173	45	-21.1375215967958	45	0.9657	0.617165643967711	Drug metabolism - other enzymes	445
1738	134	-23.4104975970331	134	0.9662	0.617165643967711	The citric acid (TCA) cycle and respiratory electron transport	1696
402	11	-8.64681299360317	11	0.9673	0.617436969654189	Ubiquinone and other terpenoid-quinone biosynthesis	1812
1410	19	-11.6576300200108	19	0.9678	0.617436969654189	Prostacyclin signalling through prostacyclin receptor	1265
103	34	-13.7384343456195	34	0.9684	0.617444866978481	Alanine, aspartate and glutamate metabolism	72
712	11	-8.90426988701334	11	0.9695	0.617771357797067	CDC6 association with the ORC:origin complex	236
1785	30	-13.3130003912783	30	0.9714	0.618606908836953	Transport of Ribonucleoproteins into the Host Nucleus	1783
24	13	-9.60731683993491	13	0.9722	0.618741370034982	glycolysis	657
1743	23	-13.4771696209475	23	0.9728	0.618748458648815	Thromboxane signalling through TP receptor	1705
1591	11	-9.56710713157581	11	0.9774	0.620812988458303	Serotonin receptors	1491
1577	47	-19.4122423919169	47	0.9783	0.620812988458303	SUMOylation of RNA binding proteins	1619
1432	11	-10.0431795879813	11	0.9784	0.620812988458303	RHO GTPases Activate NADPH Oxidases	1408
265	44	-17.2996693814013	44	0.9789	0.620812988458303	Malaria	905
1343	39	-16.7696485828493	39	0.979	0.620812988458303	PKB-mediated events*	1210
1021	30	-15.4038684084103	30	0.9803	0.62126242502348	Gluconeogenesis	638
327	39	-26.1730130640413	39	0.981	0.621331300628309	Porphyrin and chlorophyll metabolism	1229
132	41	-18.375221318228	41	0.9835	0.622291186431522	Basal transcription factors	168
1471	66	-22.090060747243	66	0.9837	0.622291186431522	RNA polymerase II transcribes snRNA genes	1437
206	27	-28.2984838990797	27	0.9858	0.623059210885812	Glucuronate pathway (uronate pathway)	642
1024	24	-28.1950813852657	24	0.9861	0.623059210885812	Glucuronidation	643
123	26	-29.5045151610702	26	0.9872	0.623379384573276	Ascorbate and aldarate metabolism	135
315	34	-32.2005107590684	34	0.9888	0.623955508457525	Pentose and glucuronate interconversions	1160
1396	27	-17.0117832513706	27	0.9893	0.623955508457525	Prefoldin mediated transfer of substrate to CCT/TriC	1244
212	23	-17.1471907247184	23	0.9907	0.624352236774841	Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate	659
1388	22	-19.9889629221209	22	0.9919	0.624352236774841	Post-chaperonin tubulin folding pathway	1232
205	15	-15.7880931018337	15	0.9926	0.624352236774841	Gluconeogenesis, oxaloacetate => fructose-6P	639
298	406	-127.610778056213	398	0.9927	0.624352236774841	Olfactory transduction	1105
795	31	-20.7956289720188	31	0.9929	0.624352236774841	Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	327
970	25	-20.7255058254852	25	0.9949	0.624994117984827	Formation of tubulin folding intermediates by CCT/TriC	575
1199	51	-25.646343727123	51	0.996	0.624994117984827	Metabolism of non-coding RNA*	941
1309	380	-145.220411063399	373	0.9961	0.624994117984827	Olfactory Signaling Pathway	1104
666	91	-78.2674663809744	91	0.9963	0.624994117984827	Antimicrobial peptides	106
832	28	-34.7632597638222	28	0.9981	0.625076105579093	Dectin-2 family	372
1680	18	-21.1479433370313	18	0.9983	0.625076105579093	Synthesis of PIPs at the Golgi membrane	1659
214	10	-17.9326603867799	10	0.9988	0.625076105579093	Glycolysis, core module involving three-carbon compounds	661
845	48	-106.858561090318	48	0.9994	0.625076105579093	Defensins	385
692	39	-104.514409515499	39	0.9999	0.625076105579093	Beta defensins	175
348	154	-56.079309015409	154	1	0.625076105579093	RNA transport	1452
